
    
<!DOCTYPE html>




<html lang="en" >
<head >
    <meta charset="UTF-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">

    <!-- Mobile properties -->
    <meta name="HandheldFriendly" content="True">
    <meta name="MobileOptimized" content="320">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">

  
    <!-- Stylesheets -->
    <link rel="stylesheet" href="/pmc/static/CACHE/css/output.cc84172e9e16.css" type="text/css">
  
  <link rel="stylesheet" href="/pmc/static/CACHE/css/output.b634933a977d.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.913c7dcab8ff.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.3766d7ad0d2d.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.e3c3c2c84eb3.css" type="text/css">

  
    <link rel="stylesheet" href="https://maxcdn.bootstrapcdn.com/font-awesome/4.7.0/css/font-awesome.min.css"/>
  
<link type="text/css" href="/pmc/static/bundles/base/base.a2ef7ca69e4b20dff539.css" rel="stylesheet" />


    <link rel="stylesheet" href="/corehtml/pmc/css/fonts/stix/stixfonts.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/3.18/pmcrefs1.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/pmc2020_1.1/ncbi_web.min.css?_=a" type="text/css" /><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-journal.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style>

    <link type="text/css" href="/pmc/static/bundles/article/article.3c5d12ff2e4beea20136.css" rel="stylesheet" />
    <link type="text/css" href="/pmc/static/django_pmc_cite_box/lib/cite-box.css" rel="stylesheet" />


    <title>LRG1 Contributes to the Pathogenesis of Multiple Kidney Diseases: A Comprehensive Review - PMC</title>

  
  <!-- Favicons -->
  <link rel="shortcut icon" type="image/ico" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon.ico" />
  <link rel="icon" type="image/png" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon.png" />

  <!-- 192x192, as recommended for Android
  http://updates.html5rocks.com/2014/11/Support-for-theme-color-in-Chrome-39-for-Android
  -->
  <link rel="icon" type="image/png" sizes="192x192" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-192.png" />

  <!-- 57x57 (precomposed) for iPhone 3GS, pre-2011 iPod Touch and older Android devices -->
  <link rel="apple-touch-icon-precomposed" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-57.png">
  <!-- 72x72 (precomposed) for 1st generation iPad, iPad 2 and iPad mini -->
  <link rel="apple-touch-icon-precomposed" sizes="72x72" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-72.png">
  <!-- 114x114 (precomposed) for iPhone 4, 4S, 5 and post-2011 iPod Touch -->
  <link rel="apple-touch-icon-precomposed" sizes="114x114" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-114.png">
  <!-- 144x144 (precomposed) for iPad 3rd and 4th generation -->
  <link rel="apple-touch-icon-precomposed" sizes="144x144" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-144.png">



    
        <!-- Logging params: Pinger defaults -->

<meta name="ncbi_app" content="pmc-frontend" />

<meta name="ncbi_db" content="pmc" />

<meta name="ncbi_phid" content="D0BD41E4AC192A45000030A9F1AAD05E.1.m_2" />


        <!-- Logging params: Pinger custom -->

<meta name="ncbi_pdid" content="article" />

<meta name="ncbi_op" content="retrieved" />

<meta name="ncbi_app_version" content="0.0" />

<meta name="ncbi_domain" content="kdd" />

<meta name="ncbi_type" content="fulltext" />

<meta name="ncbi_pcid" content="/articles/PMC11126829/" />


    


    <script>
        
            var ncbiBaseUrl = "https://www.ncbi.nlm.nih.gov";
        
        var useOfficialGovtHeader = true;
    </script>


    <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11126829/" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="citation_journal_title" content="Kidney Diseases" /><meta name="citation_title" content="LRG1 Contributes to the Pathogenesis of Multiple Kidney Diseases: A Comprehensive Review" /><meta name="citation_author" content="Chunyan Chen" /><meta name="citation_author_institution" content="Department of Nephrology, Jiaxing Hospital of Traditional Chinese Medicine, Jiaxing, China" /><meta name="citation_author" content="Jingwei Zhang" /><meta name="citation_author_institution" content="Department of Urology, Guangzhou First People&#x02019;s Hospital, Guangzhou, China" /><meta name="citation_author" content="Tao Yu" /><meta name="citation_author_institution" content="Department of Emergency Medicine, Dean People&#x02019;s Hospital, Jiujiang, China" /><meta name="citation_author" content="Haiya Feng" /><meta name="citation_author_institution" content="Department of Burn Surgery, Department of Urology, Taizhou Central Hospital (Taizhou University Hospital), Taizhou, China" /><meta name="citation_author" content="Jian Liao" /><meta name="citation_author_institution" content="Department of Nephrology, Jiaxing Hospital of Traditional Chinese Medicine, Jiaxing, China" /><meta name="citation_author" content="Yifei Jia" /><meta name="citation_author_institution" content="Department of Burn Surgery, Department of Urology, Taizhou Central Hospital (Taizhou University Hospital), Taizhou, China" /><meta name="citation_publication_date" content="2024/06" /><meta name="citation_issue" content="3" /><meta name="citation_volume" content="10" /><meta name="citation_firstpage" content="237" /><meta name="citation_doi" content="10.1159/000538443" /><meta name="citation_abstract_html_url" content="/pmc/articles/PMC11126829/?report=abstract" /><meta name="citation_fulltext_html_url" content="/pmc/articles/PMC11126829/" /><meta name="citation_pmid" content="38799248" /><meta name="DC.Title" content="LRG1 Contributes to the Pathogenesis of Multiple Kidney Diseases: A Comprehensive Review" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="Karger Publishers" /><meta name="DC.Contributor" content="Chunyan Chen" /><meta name="DC.Contributor" content="Jingwei Zhang" /><meta name="DC.Contributor" content="Tao Yu" /><meta name="DC.Contributor" content="Haiya Feng" /><meta name="DC.Contributor" content="Jian Liao" /><meta name="DC.Contributor" content="Yifei Jia" /><meta name="DC.Date" content="2024 Jun" /><meta name="DC.Identifier" content="10.1159/000538443" /><meta name="DC.Language" content="en" /><meta property="og:title" content="LRG1 Contributes to the Pathogenesis of Multiple Kidney Diseases: A Comprehensive Review" /><meta property="og:type" content="article" /><meta property="og:description" content="The increasing prevalence of kidney diseases has become a significant public health issue, with a global prevalence exceeding 10%. In order to accurately identify biochemical changes and treatment outcomes associated with kidney diseases, novel methods ..." /><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11126829/" /><meta property="og:site_name" content="PubMed Central (PMC)" /><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-card-share.jpg?_=0" /><meta name="twitter:card" content="summary_large_image" /><meta name="twitter:site" content="@ncbi" />


</head>
<body >

   
    
        <button
          class="back-to-top back-to-top--bottom"
          data-ga-category="pagination"
          data-ga-action="back_to_top">
          Back to Top
        </button>
    

    <a class="usa-skipnav" href="#main-content">Skip to main content</a>
    <!-- ========== BEGIN HEADER ========== -->
<section class="usa-banner" style="display: none;">
  <div class="usa-accordion">
    <header class="usa-banner-header">
      <div class="usa-grid usa-banner-inner">
        <img src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/favicons/favicon-57.png" alt="U.S. flag" />
        <p>An official website of the United States government</p>
        <button
          class="usa-accordion-button usa-banner-button"
          aria-expanded="false"
          aria-controls="gov-banner-top"
        >
          <span class="usa-banner-button-text">Here's how you know</span>
        </button>
      </div>
    </header>
    <div
      class="usa-banner-content usa-grid usa-accordion-content"
      id="gov-banner-top"
    >
      <div class="usa-banner-guidance-gov usa-width-one-half">
        <img
          class="usa-banner-icon usa-media_block-img"
          src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-dot-gov.svg"
          alt="Dot gov"
        />
        <div class="usa-media_block-body">
          <p>
            <strong>The .gov means it’s official.</strong>
            <br />
            Federal government websites often end in .gov or .mil. Before
            sharing sensitive information, make sure you’re on a federal
            government site.
          </p>
        </div>
      </div>
      <div class="usa-banner-guidance-ssl usa-width-one-half">
        <img
          class="usa-banner-icon usa-media_block-img"
          src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-https.svg"
          alt="Https"
        />
        <div class="usa-media_block-body">
          <p>
            <strong>The site is secure.</strong>
            <br />
            The <strong>https://</strong> ensures that you are connecting to the
            official website and that any information you provide is encrypted
            and transmitted securely.
          </p>
        </div>
      </div>
    </div>
  </div>
</section>
<div class="usa-overlay"></div>
<header class="ncbi-header" role="banner" data-section="Header">

	<div class="usa-grid">
		<div class="usa-width-one-whole">

            <div class="ncbi-header__logo">
                <a href="https://www.ncbi.nlm.nih.gov/" class="logo" aria-label="NCBI Logo" data-ga-action="click_image" data-ga-label="NIH NLM Logo">
                  <img src="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/logos/AgencyLogo.svg" alt="NIH NLM Logo" />
                </a>
            </div>

			<div class="ncbi-header__account">
				<a id="account_login" href="https://account.ncbi.nlm.nih.gov" class="usa-button header-button" style="display:none" data-ga-action="open_menu" data-ga-label="account_menu">Log in</a>
				<button id="account_info" class="header-button" style="display:none"
						aria-controls="account_popup">
					<span class="fa fa-user" aria-hidden="true"></span>
					<span class="username desktop-only" aria-hidden="true" id="uname_short"></span>
					<span class="sr-only">Show account info</span>
				</button>
			</div>

			<div class="ncbi-popup-anchor">
				<div class="ncbi-popup account-popup" id="account_popup" aria-hidden="true">
					<div class="ncbi-popup-head">
						<button class="ncbi-close-button" data-ga-action="close_menu" data-ga-label="account_menu"><span class="fa fa-times"></span><span class="usa-sr-only">Close</span></button>
						<h4>Account</h4>
					</div>
					<div class="account-user-info">
						Logged in as:<br/>
						<b><span class="username" id="uname_long">username</span></b>
					</div>
					<div class="account-links">
						<ul class="usa-unstyled-list">
							<li><a id="account_myncbi" href="/myncbi/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_myncbi">Dashboard</a></li>
							<li><a id="account_pubs" href="/myncbi/collections/bibliography/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_pubs">Publications</a></li>
							<li><a id="account_settings" href="/account/settings/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_settings">Account settings</a></li>
							<li><a id="account_logout" href="/account/signout/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_logout">Log out</a></li>
						</ul>
					</div>
				</div>
			</div>

		</div>
	</div>
</header>
<div role="navigation" aria-label="access keys">
<a id="nws_header_accesskey_0" href="https://www.ncbi.nlm.nih.gov/guide/browsers/#ncbi_accesskeys" class="usa-sr-only" accesskey="0" tabindex="-1">Access keys</a>
<a id="nws_header_accesskey_1" href="https://www.ncbi.nlm.nih.gov" class="usa-sr-only" accesskey="1" tabindex="-1">NCBI Homepage</a>
<a id="nws_header_accesskey_2" href="/myncbi/" class="set-base-url usa-sr-only" accesskey="2" tabindex="-1">MyNCBI Homepage</a>
<a id="nws_header_accesskey_3" href="#maincontent" class="usa-sr-only" accesskey="3" tabindex="-1">Main Content</a>
<a id="nws_header_accesskey_4" href="#" class="usa-sr-only" accesskey="4" tabindex="-1">Main Navigation</a>
</div>
<section data-section="Alerts">
	<div class="ncbi-alerts-placeholder"></div>
</section>
<!-- ========== END HEADER ========== -->

    
    


    
        

<section class="pmc-alerts">
    
    <div role="alert" class="pmc-alert pmc-alert--info" role="region" aria-label="Alert" aria-hidden="false"  data-key="pmc-alert-welcome">
        <div class="pmc-alert__body pmc-alert--ncbi-icon">
            <div class="pmc-alert__content">
                <p>
                    <strong>
                        Preview improvements coming to the PMC website in October 2024.
                        <a href="https://ncbiinsights.ncbi.nlm.nih.gov/2024/03/14/preview-pmc-improvements/" data-ga-category="cloud_beta_banner" data-ga-label="learn_more" data-ga-action="on_pmc2020">Learn More</a> or
                        <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11126829/" data-ga-category="cloud_beta_banner" data-ga-action="on_pmc2020" data-ga-label="go_to_cloud">Try it out now</a>.
                    </strong>
                </p>
            </div>
        </div>
    </div>
    
</section>
    

    
    
        
        <header class="pmc-header usa-header-extended" role="banner">
    <div class="pmc-header__bar">
        <div class="pmc-header__control usa-accordion">
            
                <button class="usa-menu-btn pmc-header--button pmc-header--left">
                    <i class="fa fa-ellipsis-v" aria-hidden="true"></i>
                </button>
            

            <div class="usa-logo pmc-header__logo pmc-header--stretch
                
               " id="extended-mega-logo">
                <div class="usa-logo-text">
                    <a href="/pmc/" title="Home" aria-label="Home" ></a>
                </div>
            </div>
            <button class="usa-accordion-button pmc-header--right pmc-header--button pmc-header__search--control pmc-header--right" aria-expanded="false" aria-controls="a1">
                <i class="fa fa-search" aria-hidden="true"></i>
                <i class="fa fa-times" aria-hidden="true"></i>
            </button>
        </div>
        <div class="pmc-header__search usa-accordion-content" id="a1">
            <div role="search"  class="pmc-header--stretch"  >
    <form class="usa-search " autocomplete="off">
        <div>
              <label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
              <span class="clearable">
                <input
                  required="required"
                  autocomplete-url="/pmc/autocomplete/pmc/"
                  placeholder="Search PMC Full-Text Archive"
                  id="pmc-search" type="search" name="term"/>
                  <i class="clear-btn" ></i>
              </span>
              <button type="submit" formaction="/pmc/">
                <span class="usa-search-submit-text">Search in PMC</span>
              </button>
        </div>
    </form>
</div>


            <ul class="usa-unstyled-list usa-nav-secondary-links pmc-header--offset-two">
                    <li>
                        <a href="https://www.ncbi.nlm.nih.gov/pmc/advanced" data-ga-action="featured_link" data-ga-label="advanced_search">
                            Advanced Search
                        </a>
                    </li>
                    <li>
                        <a  href="/pmc/about/userguide/" data-ga-action="featured_link"
                        data-ga-label="user guide">
                            User Guide
                        </a>
                    </li>
            </ul>
        </div>
    </div>
     <nav role="navigation" class="usa-nav ">
        <button class="usa-nav-close">
            <i class="fa fa-times" aria-hidden="true"></i>
        </button>
        <div class="usa-breadcrumb usa-breadcrumb--wrap usa-breadcrumb--hack">
             
    <ul class="usa-breadcrumb__list">
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/journals/" class="navlink">Journal List</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a class="navlink" href="/pmc/journals/3013/">Kidney Dis (Basel)</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a class="navlink" href="/pmc/issues/463320/">v.10(3); 2024 Jun</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                     aria-current="page" >
                    PMC11126829
                </li>
            
    </ul>
 

        </div>
        
        
            <div class="pmc-sidebar pmc-sidebar-hack">
                

<div class="scroller">

    
        <section>
                <h6>Other Formats</h6>
                <ul class="pmc-sidebar__formats">
                  <li class="pdf-link other_item"><a href="/pmc/articles/PMC11126829/pdf/kdd-2024-0010-0003-538443.pdf" class="int-view">PDF (415K)</a></li>
                </ul>
        </section>
    
    <section>
        <h6>Actions</h6>
        <ul class="pmc-sidebar__actions">
            <li>
                <button role="button" class="citation-button citation-dialog-trigger ctxp"
                        aria-label="Open dialog with citation text in different styles" data-ga-category="save_share" data-ga-action="cite" data-ga-label="open"
                        data-all-citations-url="/pmc/resources/citations/11126829/"
                        data-citation-style="nlm"
                        data-download-format-link="/pmc/resources/citations/11126829/export/"
                >
                    <span class="button-label">Cite</span>
                </button>
            </li>
            <li>
                
                    

<link type="text/css" href="ncbi-overlay-block/src/overlay-block.css">
<div class="collections-button-container" data-article-id="11126829" data-article-db="pmc">
  <button class="collections-button collections-dialog-trigger"
          aria-label="Save article in MyNCBI collections."
          data-ga-category="collections_button"
          data-ga-action="click"
          data-ga-label="collections_button"
          data-collections-open-dialog-enabled="false"
          data-collections-open-dialog-url="https://www.ncbi.nlm.nih.gov/account?back_url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC11126829%2F%23open-collections-dialog"
          data-in-collections="false">
      <span class="button-label">Collections</span>
  </button>
  <div class="overlay" role="dialog">
  <div id="collections-action-dialog"
       class="dialog collections-dialog"
       aria-hidden="true">
    <div class="title">Add to Collections</div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/pmc/list-existing-collections/"
      data-add-to-existing-collection-url="/pmc/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/pmc/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

  <input type="hidden" name="csrfmiddlewaretoken" value="Eqvfl3qGZqC8LNdePX4i3AXVULvHOFYI0wfTKoLZA5XCa3fOm2HBz8SB2ml8xSTL">

  

  <div class="choice-group" role="radiogroup">
    <ul class="radio-group-items">
      <li>
        <input type="radio"
               id="collections-action-dialog-new-header "
               class="collections-new"
               name="collections"
               value="new"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_new">
        <label for="collections-action-dialog-new-header ">Create a new collection</label>
      </li>
      <li>
        <input type="radio"
               id="collections-action-dialog-existing-header "
               class="collections-existing"
               name="collections"
               value="existing"
               checked="true"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_existing">
        <label for="collections-action-dialog-existing-header ">Add to an existing collection</label>
      </li>
    </ul>
  </div>

  <div class="controls-wrapper">
    <div class="action-panel-control-wrap new-collections-controls">
      <label for="collections-action-dialog-add-to-new" class="action-panel-label required-field-asterisk">
        Name your collection:
      </label>
      <input
        type="text"
        name="add-to-new-collection"
        id="collections-action-dialog-add-to-new"
        class="collections-action-add-to-new"
        pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
        maxlength=""
        data-ga-category="collections_button"
        data-ga-action="create_collection"
        data-ga-label="non_favorties_collection">
      <div class="collections-new-name-too-long usa-input-error-message selection-validation-message">
        Name must be less than  characters
      </div>
    </div>
    <div class="action-panel-control-wrap existing-collections-controls">
      <label for="collections-action-dialog-add-to-existing" class="action-panel-label">
        Choose a collection:
      </label>
      <select id="collections-action-dialog-add-to-existing"
              class="action-panel-selector collections-action-add-to-existing"
              data-ga-category="collections_button"
              data-ga-action="select_collection"
              data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
      </select>
      <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
        Unable to load your collection due to an error<br>
        <a href="#">Please try again</a>
      </div>
    </div>
  </div>

  <div class="action-panel-actions">
    <button class="action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
      Add
    </button>
    <button class="action-panel-cancel"
            aria-label="Close 'Add to Collections' panel"
            ref="linksrc=close_collections_panel"
            aria-controls="collections-action-panel"
            aria-expanded="false"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="cancel">
      Cancel
    </button>
  </div>
</form>
    </div>
  </div>
</div>
</div>
                
            </li>

        </ul>
    </section>
    
        <section class="social-sharing">
            <h6>Share</h6>
            <ul class="pmc-sidebar__share">
                <li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC11126829%2F&amp;text=LRG1%20Contributes%20to%20the%20Pathogenesis%20of%20Multiple%20Kidney%20Diseases%3A%20A%20Comprehensive%20Review" alt="Share on Twitter"><i class="fa fa-twitter fa-stack-1x">&#160;</i></a></li> 
<li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC11126829%2F" alt="Share on Facebook"><i class="fa fa-facebook fa-stack-1x">&#160;</i></a></li>
                <li>
                    <div class="share-permalink">
                        <button class="trigger"  alt="Show article permalink" aria-expanded="false" aria-haspopup="true">
                            <i class="fa-stack fa-lg" >
                                <i class="fa fa-link fa-stack-1x">&nbsp;</i>
                            </i>
                        </button>
                        <div class="dropdown dropdown-container" hidden>
                              <div class="title">
                                Permalink
                              </div>
                              <div class="content">
                                  <input type="text" class="permalink-text" value="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11126829/" aria-label="Article permalink"><button class="permalink-copy-button usa-button-primary" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                                      <span class="button-title">Copy</span>
                                  </button>
                              </div>
                        </div>
                    </div>
                </li>
            </ul>
        </section>
    
    <section>
        <h6>RESOURCES</h6>
        <ul class="pmc-sidebar__resources">
        
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_similar_articles"
                            data-ga-label="/pmc/articles/PMC11126829/"
                            class="usa-accordion-button"
                            aria-controls="similar-articles-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_similar_articles"
                            data-action-close="close_similar_articles"
                    >
                        Similar articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/similar-article-links/38799248/"
                            

                         class="usa-accordion-content pmc-sidebar__resources--citations" id="similar-articles-accordion-header" aria-hidden="true">
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_cited_by"
                            data-ga-label="/pmc/articles/PMC11126829/"
                            class="usa-accordion-button"
                            aria-controls="cited-by-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_cited_by"
                            data-action-close="close_cited_by"
                    >
                        Cited by other articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/cited-by-links/38799248/"
                            
                            class="usa-accordion-content pmc-sidebar__resources--citations"
                            id="cited-by-accordion-header"
                            aria-hidden="true"
                    >
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/pmc/articles/PMC11126829/"
                            class="usa-accordion-button"
                            aria-controls="links-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                    >
                        Links to NCBI Databases
                    </button>
                    <div data-source-url="/pmc/resources/db-links/11126829/" class="usa-accordion-content" id="links-accordion-header" aria-hidden="true"></div>
                </div>
            </li>

            
        
        </ul>
    </section>

 </div>
            </div>
        

    </nav>

</header>

    
    

    <div class="usa-overlay"></div>
    
<main id="main-content" class="usa-grid usa-layout-docs pmc-main">
    <article class="usa-width-three-fourths usa-layout-docs-main_content pmc-article">
        <section class="usa-breadcrumb usa-breadcrumb--wrap">
         
    <ul class="usa-breadcrumb__list">
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/journals/" class="navlink">Journal List</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a class="navlink" href="/pmc/journals/3013/">Kidney Dis (Basel)</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a class="navlink" href="/pmc/issues/463320/">v.10(3); 2024 Jun</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                     aria-current="page" >
                    PMC11126829
                </li>
            
    </ul>
 

        </section>
        
  <div class="pmc-article__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/pmc/about/disclaimer/">PMC Disclaimer</a>
    |
    <a data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/pmc/about/copyright/">
        PMC Copyright Notice
    </a>
</div>

        <section class="pmc-page-banner" role="banner">
            
                
                    <div><img src="/corehtml/pmc/pmcgifs/logo-kdd.jpg" alt="Logo of kdd" usemap="#logo-imagemap" /><map id="logo-imagemap" name="logo-imagemap"><area alt="Link to Publisher's site" title="Link to Publisher's site" shape="default" coords="0,0,499,74" href="http://www.karger.com/KDD" target="_blank" rel="noopener noreferrer" ref="reftype=publisher&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" /></map></div> 
                
            
        </section>
        <section  role="document">
            
                <div id="mc" class=" article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden,.nomenu'"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-flexbox"><div class="fm-citation"><div class="citation-default"><div class="part1"><span id="pmcmata">Kidney Dis (Basel).</span> 2024 Jun; 10(3): 237–248. </div><div class="part2"><span class="fm-vol-iss-date">Published online 2024 Apr 3. </span>  <span class="doi"><span>doi: </span><a href="//doi.org/10.1159%2F000538443" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.1159/000538443</a></span></div></div></div><div class="fm-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC11126829</span></div><div class="fm-citation-pmid">PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/38799248">38799248</a></div></div></div><h1 class="content-title">LRG1 Contributes to the Pathogenesis of Multiple Kidney Diseases: A Comprehensive Review</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=Chen%20C%5BAuthor%5D" class="affpopup" co-rid="_co_idm140470114640080" co-class="co-affbox">Chunyan Chen</a>,<sup>
a
</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Zhang%20J%5BAuthor%5D" class="affpopup" co-rid="_co_idm140470114636976" co-class="co-affbox">Jingwei Zhang</a>,<sup>
b
</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Yu%20T%5BAuthor%5D" class="affpopup" co-rid="_co_idm140470114633872" co-class="co-affbox">Tao Yu</a>,<sup>
c
</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Feng%20H%5BAuthor%5D" class="affpopup" co-rid="_co_idm140470114630768" co-class="co-affbox">Haiya Feng</a>,<sup>
d
</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Liao%20J%5BAuthor%5D" class="affpopup" co-rid="_co_idm140470113620016" co-class="co-affbox">Jian Liao</a>,<sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author" /></sup><sup>
a
</sup> and  <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Jia%20Y%5BAuthor%5D" class="affpopup" co-rid="_co_idm140470113616672" co-class="co-affbox">Yifei Jia</a><sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author" /></sup><sup>
d
</sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm140470114640080"><h3 class="no_margin">Chunyan Chen</h3><p><sup>a</sup>Department of Nephrology, Jiaxing Hospital of Traditional Chinese Medicine, Jiaxing, China</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Chen%20C%5BAuthor%5D">Chunyan Chen</a></div></div><div id="_co_idm140470114636976"><h3 class="no_margin">Jingwei Zhang</h3><p><sup>b</sup>Department of Urology, Guangzhou First People&#x02019;s Hospital, Guangzhou, China</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Zhang%20J%5BAuthor%5D">Jingwei Zhang</a></div></div><div id="_co_idm140470114633872"><h3 class="no_margin">Tao Yu</h3><p><sup>c</sup>Department of Emergency Medicine, Dean People&#x02019;s Hospital, Jiujiang, China</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Yu%20T%5BAuthor%5D">Tao Yu</a></div></div><div id="_co_idm140470114630768"><h3 class="no_margin">Haiya Feng</h3><p><sup>d</sup>Department of Burn Surgery, Department of Urology, Taizhou Central Hospital (Taizhou University Hospital), Taizhou, China</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Feng%20H%5BAuthor%5D">Haiya Feng</a></div></div><div id="_co_idm140470113620016"><h3 class="no_margin">Jian Liao</h3><p><sup>a</sup>Department of Nephrology, Jiaxing Hospital of Traditional Chinese Medicine, Jiaxing, China</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Liao%20J%5BAuthor%5D">Jian Liao</a></div></div><div id="_co_idm140470113616672"><h3 class="no_margin">Yifei Jia</h3><p><sup>d</sup>Department of Burn Surgery, Department of Urology, Taizhou Central Hospital (Taizhou University Hospital), Taizhou, China</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Jia%20Y%5BAuthor%5D">Yifei Jia</a></div></div></div></div><div class="half_rhythm"><div class="togglers fm-copyright-license"><a href="#" class="pmctoggle" rid="idm140470114820992_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm140470114820992_an">Article notes</a> <a href="#" class="pmctoggle" rid="idm140470114820992_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/" style="margin-left: 1em">PMC Disclaimer</a></div><div class="fm-authors-info hide half_rhythm" id="idm140470114820992_ai" style="display:none"><div class="fm-affl" id="aff1"><sup>a</sup>Department of Nephrology, Jiaxing Hospital of Traditional Chinese Medicine, Jiaxing, China</div><div class="fm-affl" id="aff2"><sup>b</sup>Department of Urology, Guangzhou First People&#x02019;s Hospital, Guangzhou, China</div><div class="fm-affl" id="aff3"><sup>c</sup>Department of Emergency Medicine, Dean People&#x02019;s Hospital, Jiujiang, China</div><div class="fm-affl" id="aff4"><sup>d</sup>Department of Burn Surgery, Department of Urology, Taizhou Central Hospital (Taizhou University Hospital), Taizhou, China</div><div><sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author" /></sup>Corresponding author.</div><div id="cor1">Correspondence to: Jian Liao, <a href="mailto:dev@null" data-email="moc.361@0202rdnaijoail" class="oemail">moc.361@0202rdnaijoail</a> or Yifei Jia, <a href="mailto:dev@null" data-email="ten.haey@9102aijiefiy" class="oemail">ten.haey@9102aijiefiy</a></div><div id="fn-a.g.b.f.b">Chunyan Chen, Jingwei Zhang, and Tao Yu contributed equally to this work.</div></div><div class="fm-article-notes hide half_rhythm" id="idm140470114820992_an" style="display:none"><div class="fm-pubdate half_rhythm">Received 2023 Aug 23; Accepted 2024 Mar 8.</div></div><div class="permissions half_rhythm hide" id="idm140470114820992_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright</a> &#x000a9; 2024 The Author(s). Published by S. Karger AG, Basel</div><div class="license half_rhythm">This article is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC) (<a href="http://www.karger.com/Services/OpenAccessLicense" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CFront%20Matter&amp;TO=External%7CLink%7CURI" target="_blank">http://www.karger.com/Services/OpenAccessLicense</a>). Usage and distribution for commercial purposes requires written permission.</div></div></div><div id="pmclinksbox" class="links-box whole_rhythm hidden" role="complementary" aria-label="Related or updated information about this article."></div></div><div class="sec"></div><div id="abstract-a.g.b.o" lang="en" class="tsec sec"><h2 class="head no_bottom_margin" id="abstract-a.g.b.otitle">Abstract</h2><!--article-meta--><div><div id="sec-a.g.b.o.b" class="sec sec-first"><h3 id="sec-a.g.b.o.btitle">Background</h3><p class="p p-first-last">The increasing prevalence of kidney diseases has become a significant public health issue, with a global prevalence exceeding 10%. In order to accurately identify biochemical changes and treatment outcomes associated with kidney diseases, novel methods targeting specific genes have been discovered. Among these genes, leucine-rich &#x003b1;-2 glycoprotein 1 (LRG1) has been identified to function as a multifunctional pathogenic signaling molecule in multiple diseases, including kidney diseases. This study aims to provide a comprehensive overview of the current evidence regarding the roles of LRG1 in different types of kidney diseases.</p></div><div id="sec-a.g.b.o.c" class="sec"><h3 id="sec-a.g.b.o.ctitle">Summary</h3><p class="p p-first-last">Based on a comprehensive review, it was found that LRG1 was upregulated in the urine, serum, or renal tissues of patients or experimental animal models with multiple kidney diseases, such as diabetic nephropathy, kidney injury, IgA nephropathy, chronic kidney diseases, clear cell renal cell carcinoma, end-stage renal disease, canine leishmaniosis-induced kidney disease, kidney fibrosis, and aristolochic acid nephropathy. Mechanistically, the role of LRG1 in kidney diseases is believed to be detrimental, potentially through its regulation of various genes and signaling cascades, i.e., fibronectin 1, GPR56, vascular endothelial growth factor (VEGF), VEGFR-2, death receptor 5, GDF15, HIF-1&#x003b1;, SPP1, activin receptor-like kinase 1-Smad1/5/8, NLRP3-IL-1b, and transforming growth factor &#x003b2; pathway.</p></div><div id="sec-a.g.b.o.d" class="sec sec-last"><h3 id="sec-a.g.b.o.dtitle">Key Messages</h3><p class="p p-first-last">Further research is needed to fully comprehend the molecular mechanisms by which LRG1 contributes to the pathogenesis and pathophysiology of kidney diseases. It is anticipated that targeted treatments focusing on LRG1 will be utilized in clinical trials and implemented in clinical practice in the future.</p></div></div><div class="sec"><strong class="kwd-title">Keywords: </strong><span class="kwd-text">Leucine-rich &#x003b1;-2 glycoprotein 1, Kidney disease, Diabetic nephropathy, Kidney injury, Biomarker, Transforming growth factor &#x003b2;</span></div></div><div id="s1" class="tsec sec"><h2 class="head no_bottom_margin" id="s1title">Introduction</h2><p class="p p-first">Kidney diseases, which encompass acute kidney injury (AKI) and chronic kidney diseases (CKDs), are increasingly recognized as significant global public health concerns. The global prevalence of kidney diseases exceeds 10% [<a href="#B1" rid="B1" class=" bibr popnode">1</a>]. As a vital organ, the kidney functions as the maintenance of electrolyte balance, the stability of blood pH, removal of metabolic waste, and reabsorption of nutrients and minerals for the body [<a href="#B2" rid="B2" class=" bibr popnode">2</a>]. Additionally, the kidney also regulates blood pressure, vitamin D maturation, and erythropoiesis. Under the pathophysiological conditions (i.e., long-term starvation, fasting, and insulin resistance), the kidney can produce glucose through the action of gluconeogenesis. Heavy workload on the kidneys and exposure to various risk factors can cause the development and the progression of kidney diseases or renal injuries. Individuals with CKD are found to be associated with an increased risk of AKI, while AKI increases the susceptibility to developing CKD. In severe cases, AKI can lead to acute renal failure. On the other hand, CKD may inevitably progress into end-stage kidney disease (ESKD) [<a href="#B3" rid="B3" class=" bibr popnode">3</a>, <a href="#B4" rid="B4" class=" bibr popnode">4</a>]. Both renal failure and ESKD seriously threaten the sufferer&#x02019;s life. By 2040, CKD is projected to become the world's fifth leading cause of death [<a href="#B5" rid="B5" class=" bibr popnode">5</a>].</p><p>To date, few pharmaceutical products are available for the treatment of AKI or CKD. In AKI, continuous renal replacement therapy is designed to maintain hydroelectrolyte balance and acid-base balance, as well as alleviate the symptoms of uremia in patients by continuously removing metabolites and fluids from the body [<a href="#B6" rid="B6" class=" bibr popnode">6</a>]. Renal dialysis is the conventional strategy to treat advanced or the terminal-stage CKD [<a href="#B7" rid="B7" class=" bibr popnode">7</a>]. Nevertheless, challenges remain in some uncontrolled cases, which dramatically increase the morbidity and mortality of the sufferers [<a href="#B8" rid="B8" class=" bibr popnode">8</a>]. Therefore, additional studies are still warranted to address these diseases. At present, numerous therapeutic approaches have been explored to fight kidney diseases. Novel methods targeted with associated genes and cell-signaling processes have been found to provide the precise identification of biochemical changes and treatment outcomes of kidney diseases [<a href="#B9" rid="B9" class=" bibr popnode">9</a>].</p><p class="p p-last">Leucine-rich &#x003b1;-2 glycoprotein 1 (LRG1), a secreted protein of the family of leucine-rich repeats (LRRs), functions as a multifunctional pathogenic signaling molecule in various diseases [<a href="#B10" rid="B10" class=" bibr popnode">10</a>]. LRG1 can modulate the transforming growth factor &#x003b2; (TGF-&#x003b2;) pathway through a highly context-dependent manner, involving in the pathological angiogenesis [<a href="#B11" rid="B11" class=" bibr popnode">11</a>]. TGF-&#x003b2; serves as an important pro-fibrotic growth factor that is activated in the process of AKI [<a href="#B12" rid="B12" class=" bibr popnode">12</a>]. Furthermore, there exists a correlation between cellular responses and the onset of CKD [<a href="#B13" rid="B13" class=" bibr popnode">13</a>]. Additionally, the involvement of angiogenesis in the pathophysiological progression of kidney diseases has been established [<a href="#B14" rid="B14" class=" bibr popnode">14</a>]. Given the intimate association between the TGF-&#x003b2; pathway and the development of kidney diseases, it is plausible that LRG1 also assumes a crucial function in these conditions. Currently, since the absence of pertinent literature reviews examining the roles of LRG1 in kidney diseases, it is imperative to undertake a comprehensive review based on the existing evidence.</p></div><div id="s1-1" class="tsec sec"><h2 class="head no_bottom_margin" id="s1-1title">Overview of LRG1</h2><p class="p p-first">LRG1, originally separated from human serum in 1977, belongs to the leucine-rich repeating family [<a href="#B15" rid="B15" class=" bibr popnode">15</a>]. It is composed of eight LRRs with a majority of 20&#x02013;30 amino acid residues in length [<a href="#B16" rid="B16" class=" bibr popnode">16</a>]. This gene is located on the short arm of chromosome 19, band 3, and region 13. The amino acid sequence of LRG1 contains 312 amino acids, which was confirmed in 1985 [<a href="#B17" rid="B17" class=" bibr popnode">17</a>]. LRG1, a glycoprotein with 5 glycosylation sites, is 45 kDa in molecular weight with a 4.52 to 4.72 isoelectric point. According to predictions, LRG1 contains several loops connecting its leucine-rich C-terminal domain to its LRRs. Functionally, LRG1 participates in various cellular processes, e.g., signal transduction, cell differentiation, proliferation, migration, apoptosis, and cell cycle progression, etc [<a href="#B18" rid="B18" class=" bibr popnode">18</a>]. Intracellularly, plasma LRG1 interacted with cytochrome c which is a small soluble electron carrier hemeprotein [<a href="#B19" rid="B19" class=" bibr popnode">19</a>, <a href="#B20" rid="B20" class=" bibr popnode">20</a>]. Though the physiological function of LRG1 remains poorly understood, the LRG1 gene is one of the factors that promote vascular dysfunction and pathological angiogenesis. LRG1 has been found to regulate TGF-&#x003b2; signaling in a variety of diseases, switching the phenotype from a quiescent to an active angiogenic state [<a href="#B11" rid="B11" class=" bibr popnode">11</a>]. Commonly, LRG1 binds to the TGF-&#x003b2; type II receptor accessory receptor endoglin and in conjunction with TGF-&#x003b2;, thus promoting the pro-angiogenic Smad1/5/8 cascade. The activin receptor-like kinase 1 (ALK1) and 5 (ALK5) are the two receptors through which TGF-&#x003b2; type II receptor initiates canonical signaling [<a href="#B21" rid="B21" class=" bibr popnode">21</a>]. The LRG1 protein is capable of regulating the pathogenic neovascularization by transforming TGF-&#x003b2; cascade toward a proliferative pattern in endothelial cells [<a href="#B22" rid="B22" class=" bibr popnode">22</a>]. However, LRG1 was also identified to modify the cell migratory machinery via the upstream modulation of noncanonical TGF-&#x003b2; signaling, e.g., FAK-ERK and Wnt/&#x003b2;-catenin pathway [<a href="#B23" rid="B23" class=" bibr popnode">23</a>, <a href="#B24" rid="B24" class=" bibr popnode">24</a>].</p><p class="p p-last">According to published data, LRG1 has been implicated in the pathogenesis of multiple diseases, e.g., diabetes, cancer, and kidney diseases [<a href="#B19" rid="B19" class=" bibr popnode">19</a>]. A variety of cellular targets are targeted by LRG1 to mediate pathogenic mechanisms. These include epithelial, endothelial, immune, age-related macular degeneration, and mesenchymal cells. Under homoeostatic conditions, LRG1 is produced primarily by hepatocytes and granulocytes with a concentration of 10&#x02013;50 &#x003bc;g/mL in serum [<a href="#B25" rid="B25" class=" bibr popnode">25</a>], but its plasma levels are often elevated during acute and chronic pathological states [<a href="#B19" rid="B19" class=" bibr popnode">19</a>]. As reported, a different glycosylation pattern is observed in neutrophil-derived LRG1 and serum-derived LRG1 [<a href="#B26" rid="B26" class=" bibr popnode">26</a>]. Confirmed by in situ co-hybridization and immunohistochemistry on laser-captured glomeruli, LRG1 was found to express in kidney endothelial cells [<a href="#B27" rid="B27" class=" bibr popnode">27</a>], indicating LRG1 may involve in the development of renal diseases. The objective of this study was to provide a comprehensive review of the existing literature on LRG1, focusing specifically on its biological significance in kidney diseases.</p></div><div id="s1-2" class="tsec sec"><h2 class="head no_bottom_margin" id="s1-2title">Diabetic Nephropathy</h2><p class="p p-first">Diabetes nephropathy is common renal disease associated with long terms of diabetes mellitus. Its complications include proteinuria, reduction in glomerular filtration, glomerular enlargement, and renal fibrosis [<a href="#B28" rid="B28" class=" bibr popnode">28</a>]. In some certain regions, the prevalence of diabetes nephropathy in adults was recorded over 20% [<a href="#B29" rid="B29" class=" bibr popnode">29</a>]. Diabetes nephropathy-associated heart failure with unchanged ejection fraction is the common causes of deaths and morbidity in patients with diabetes nephropathy. With the exception of renal replacement therapy, few therapeutic strategies were turned out to be ineffective for treating diabetes nephropathy. To obtain an effective, rapid, and noninvasive method for detecting DN early and predicting its prognosis, many biomarkers have been detected to participate in the pathophysiological mechanisms in diabetes nephropathy.</p><p>One such molecular is LRG1. As shown in <a href="/pmc/articles/PMC11126829/table/T1/" target="table" class="fig-table-link figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""><span>Table 1</span></a>, eight included studies reported the relationship between LRG1 and the development of diabetes nephropathy.</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap anchored whole_rhythm" id="T1"><h3>Table 1.</h3><!--caption a7--><div class="caption"><p>Role of LRG1 in diabetic nephropathy</p></div><div class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th rowspan="1" colspan="1">Study/reference</th><th rowspan="1" colspan="1">Study objects</th><th rowspan="1" colspan="1">Kidney disease</th><th rowspan="1" colspan="1">LRG1 expression</th><th rowspan="1" colspan="1">Associated genes or pathways</th><th rowspan="1" colspan="1">Main findings</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Singh et al. [<a href="#B30" rid="B30" class=" bibr popnode">30</a>] (2017)</td><td rowspan="1" colspan="1">Patients (<em>n</em> = 220)</td><td rowspan="1" colspan="1">Diabetic kidney disease</td><td rowspan="1" colspan="1">Up in urine</td><td rowspan="1" colspan="1">Activated FN1</td><td rowspan="1" colspan="1">LRG1 was 3.5 times more abundant in patients with type 1 diabetes than the healthy controls. LRG1 interacted with FN1, together contributed to the development of diabetic kidney disease</td></tr><tr><td rowspan="1" colspan="1">Fu et al. [<a href="#B33" rid="B33" class=" bibr popnode">33</a>] (2018)</td><td rowspan="1" colspan="1">Cells and mice</td><td rowspan="1" colspan="1">Diabetic nephropathy</td><td rowspan="1" colspan="1">Up in glomerular endothelial cells and renal tissue (glomeruli)</td><td rowspan="1" colspan="1">Activated GPR56</td><td rowspan="1" colspan="1">High glucose conditions elevated both LRG1 and GPR56 expressions. These two genes also increased in STZ glomeruli. They were implicated in regulation of angiogenesis</td></tr><tr><td rowspan="1" colspan="1">Haku et al. [<a href="#B35" rid="B35" class=" bibr popnode">35</a>] (2018)</td><td rowspan="1" colspan="1">Cells and mice</td><td rowspan="1" colspan="1">Diabetic nephropathy</td><td rowspan="1" colspan="1">Up in glomerular endothelial cells</td><td rowspan="1" colspan="1">Activated VEGF and VEGFR-2</td><td rowspan="1" colspan="1">LRG1 directly binds to the TGF-&#x003b2; accessory receptor ENG and TGF-&#x003b2; receptor-II. LRG1 played roles in the development of diabetic nephropathy by enhancing aberrant angiogenesis and glomerular hypertrophy</td></tr><tr><td rowspan="1" colspan="1">Hong et al. [<a href="#B27" rid="B27" class=" bibr popnode">27</a>] (2019)</td><td rowspan="1" colspan="1">Patients, cells, and mice</td><td rowspan="1" colspan="1">Diabetic kidney disease</td><td rowspan="1" colspan="1">Up in plasma</td><td rowspan="1" colspan="1">ALK1-Smad1/5/8 activation</td><td rowspan="1" colspan="1">LRG1 predominantly localized in glomerular endothelial cells. Its expression increased in the diabetic kidneys by activating ALK1-Smad1/5/8. Inhibition of LRG1 significantly alleviated diabetes-induced glomerular angiogenesis and podocyte loss. Elevation of plasma LRG1 was correlated to worse renal outcome in patients with DM</td></tr><tr><td rowspan="1" colspan="1">Gurung et al. [<a href="#B32" rid="B32" class=" bibr popnode">32</a>] (2021)</td><td rowspan="1" colspan="1">Patients (<em>n</em> = 1,813)</td><td rowspan="1" colspan="1">Diabetic nephropathy</td><td rowspan="1" colspan="1">Up in plasma</td><td rowspan="1" colspan="1">SNP (rs4806985)</td><td rowspan="1" colspan="1">High plasma LRG1 increased the risk of longitudinal decline in kidney function. SNP (rs4806985) was robustly associated with the expression of LRG1</td></tr><tr><td rowspan="1" colspan="1">Jiang et al. [<a href="#B38" rid="B38" class=" bibr popnode">38</a>] (2022)</td><td rowspan="1" colspan="1">Cells and mice</td><td rowspan="1" colspan="1">Diabetic nephropathy</td><td rowspan="1" colspan="1">Up in renal tissues and cells</td><td rowspan="1" colspan="1">Activated TGF-&#x003b2;R1 and death receptor 5 (DR5)</td><td rowspan="1" colspan="1">LRG1-enriched extracellular vesicles activated macrophages via a TGF-&#x003b2;R1-dependent process. TNF-related apoptosis-inducing ligand-enriched extracellular vesicles induced apoptosis in injured TECs via a death receptor 5 (DR5)-dependent process</td></tr><tr><td rowspan="1" colspan="1">Liu et al. [<a href="#B31" rid="B31" class=" bibr popnode">31</a>] (2023)</td><td rowspan="1" colspan="1">Patients (<em>n</em> = 134)</td><td rowspan="1" colspan="1">Type 2 diabetes-induced ESKD</td><td rowspan="1" colspan="1">Up in urine</td><td rowspan="1" colspan="1">TGF-&#x003b2; signaling</td><td rowspan="1" colspan="1">After adjustment of the common risk factors, patients with high level of LRG1 had a 1.91-fold (95% CI: 1.04&#x02013;3.50, <em>p</em>
<span style="color:#FE0191">=</span> 0.04) increased risk of progression to ESKD. Urine LRG1 was correlated to rapid declination of kidney function and progression to macroalbuminuria</td></tr><tr><td rowspan="1" colspan="1">Mohammad et al. [<a href="#B37" rid="B37" class=" bibr popnode">37</a>] (2023)</td><td rowspan="1" colspan="1">Cells and rats</td><td rowspan="1" colspan="1">Diabetic nephropathy</td><td rowspan="1" colspan="1">Up in renal tissues and cells</td><td rowspan="1" colspan="1">Activated TGF-&#x003b2;1/ALK1</td><td rowspan="1" colspan="1">LRG1 increased in rat model of diabetic nephropathy, while metformin reversed this tendency, which might be correlated to the inhibition of TGF-&#x003b2;1/ALK1-induced angiogenesis and the protection of ultrastructural changes</td></tr></tbody></table></div><div class="largeobj-link align_right" id="largeobj_idm140470075747328"><a target="object" rel="noopener" href="/pmc/articles/PMC11126829/table/T1/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="fn-a.h.c.d.d.a"><p class="p p-first-last">eGFR, estimated glomerular filtration rate; AKI, acute kidney injury; CKD, chronic kidney disease; FN1, fibronectin 1.</p></div></div></div><p>Consistently, all the eight eligible studies demonstrated that the level LRG1 was elevated in urine, serum, or kidney tissues of a condition of diabetes nephropathy. There were three clinical studies in this section. Singh et al. [<a href="#B30" rid="B30" class=" bibr popnode">30</a>] recruited 220 young patients (3&#x02013;18 years of age) with type 1 diabetes kidney disease and found that the expression of LRG1 was increased in urine samples. LRG1 level was 3.5 times more abundant in patients with type 1 diabetes than the healthy controls. Mechanistically, high level of LRG1 might interact with its associated protein fibronectin 1, together contributed to the development of diabetic kidney disease. Patients with type 1 diabetes might present with membrane damage in lysosomes of renal tubular epithelial cells (TECs). The authors concluded that LRG1 might serve as a promising inflammation and neovascularization biomarker in diabetic kidney disease. In line with the findings by Singh et al., Liu et al. [<a href="#B31" rid="B31" class=" bibr popnode">31</a>] also reported that LRG1 was upregulated in the urine of patients with type 2 diabetes-induced ESKD. After adjustment of the common risk factors, patients with high level of LRG1 had a 1.91-fold (95% CI: 1.04&#x02013;3.50, <em>p</em> = 0.04) increased risk of progression to ESKD. Urine LRG1 was correlated to rapid declination of kidney function and progression to macroalbuminuria. The possible pathophysiological mechanisms linking urine LRG1 and progressive diabetic kidney disease might be associated with amplification of the TGF-&#x003b2; signaling cascade in the diabetic kidneys. In addition to the high level of LRG1 in urine, in a large-sample study (<em>n</em> = 1,813) developed by Gurung et al. [<a href="#B32" rid="B32" class=" bibr popnode">32</a>], it demonstrated that LRG1 was elevated in plasma of patients with diabetic nephropathy. The author further found that high plasma LRG1 increased the risk of longitudinal decline in kidney function, while SNP (rs4806985) was robustly associated with the expression of LRG1. It was possible that plasma LRG1 might play a causal role in progression of diabetic nephropathy at an early stage of CKD. The aforementioned three clinical studies have demonstrated that patients with diabetic nephropathy exhibited heightened levels of LRG1 in both urine and plasma.</p><p class="p p-last">Five experimental studies reported the roles of LRG1 in cell or animal models of diabetic kidney disease. All these included studies confirmed LRG1 was increased in glomerular endothelial cells, serum, urine, and renal tissues of the in vitro and in vivo models. In the study by Fu et al. [<a href="#B33" rid="B33" class=" bibr popnode">33</a>], upregulated LRG1 in glomerular endothelial cells and renal tissue (glomeruli) was observed in high glucose-mediated cells and streptozotocin-induced diabetic mice. High-glucose conditions elevated both LRG1 and GPR56 expression. These two genes also increased in STZ glomeruli, implicating in regulation of angiogenesis in the glomerulopathy of diabetic mice. LRG1 has been found to directly bind to endoglin, a TGF-&#x003b2; accessory receptor, together form the complex bind to TGF-&#x003b2; receptor-II (T&#x003b2;RII) [<a href="#B11" rid="B11" class=" bibr popnode">11</a>]. Vascular endothelial growth factor (VEGF) functions to regulate abnormal angiogenesis. The glomerular expression of VEGF was found to contribute to early stage diabetic nephropathy [<a href="#B34" rid="B34" class=" bibr popnode">34</a>]. Haku et al. [<a href="#B35" rid="B35" class=" bibr popnode">35</a>] found that the expression of LRG1 raised in glomerular endothelial cells in diabetic db/db mice. Increased LRG1 expression might prior to the elevation of VEGF expression. The authors revealed that LRG1 played roles in the development of diabetic nephropathy by enhancing aberrant angiogenesis and glomerular hypertrophy. LRG1 promotes neovascularization by enhancing endothelial TGF-&#x003b2;/ALK1 signaling [<a href="#B36" rid="B36" class=" bibr popnode">36</a>]. Hong et al. [<a href="#B27" rid="B27" class=" bibr popnode">27</a>] showed that LRG1 level was increased in plasma of diabetic mice. LRG1 predominantly localized in glomerular endothelial cells. Its expression increased in the diabetic kidneys by activating ALK1-Smad1/5/8. Inhibition of LRG1 significantly alleviated diabetes-induced glomerular angiogenesis and podocyte loss. Elevation of plasma LRG1 was correlated to worse renal outcome in patients with diabetic kidney disease. Consistent with the study by Hong et al. on the association between LRG1 and ALK1, Mohammad et al. [<a href="#B37" rid="B37" class=" bibr popnode">37</a>] reported that the LRG1 expression was up in renal tissues and cells. LRG1 increased in rat model of diabetic nephropathy, while metformin reversed this tendency, which might be correlated to the inhibition of TGF-&#x003b2;1/ALK1-induced angiogenesis and the protection of ultrastructural changes. Death receptor 5 (DR5) is found to correlate with kidney function decline. A recent study reported by Jiang et al. [<a href="#B38" rid="B38" class=" bibr popnode">38</a>] suggested that LRG1 was up in renal tissues and cells. The authors indicated that LRG1-enriched extracellular vesicles activated macrophages via a TGF-&#x003b2;R1-dependent process. TNF-related apoptosis-inducing ligand-enriched extracellular vesicles induced apoptosis in injured TECs via a DR5-dependent process. LRG1/TGF-&#x003b2;R1 signaling could elevate tumor necrosis factor-related apoptosis-inducing ligand expression in macrophages. These eligible studies have indicated that elevated LRG1 expression contributes to the progression of diabetes mellitus, thereby offering potential insights for the development of improved therapeutic interventions.</p></div><div id="s1-3" class="tsec sec"><h2 class="head no_bottom_margin" id="s1-3title">Acute Kidney Injury</h2><p class="p p-first">AKI is one of the common kidney diseases and is associated with the subsequent progression of CKD. It occurs in nearly half of patients with critically ill, correlating with increased in-hospital mortality and long-term mortality postdischarge [<a href="#B39" rid="B39" class=" bibr popnode">39</a>]. Five included studies reported the roles of LRG1 in kidney injury (<a href="/pmc/articles/PMC11126829/table/T2/" target="table" class="fig-table-link figpopup" rid-figpopup="T2" rid-ob="ob-T2" co-legend-rid=""><span>Table 2</span></a>). Three of them were the clinical studies, while the remainder two studies were experimental designed. All of five included studies confirmed that LRG1 was upregulated in the serum, urine, and kidney tissues of the patients or experimental models of kidney injury.</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap anchored whole_rhythm" id="T2"><h3>Table 2.</h3><!--caption a7--><div class="caption"><p>Role of LRG1 in kidney injury</p></div><div class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th rowspan="1" colspan="1">Study/reference</th><th rowspan="1" colspan="1">Study objects</th><th rowspan="1" colspan="1">Kidney disease</th><th rowspan="1" colspan="1">LRG1 expression</th><th rowspan="1" colspan="1">Associated genes or pathways</th><th rowspan="1" colspan="1">Main findings</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Hashida et al. [<a href="#B40" rid="B40" class=" bibr popnode">40</a>] (2017)</td><td rowspan="1" colspan="1">Patients (<em>n</em> = 20)</td><td rowspan="1" colspan="1">Sepsis-induced AKI</td><td rowspan="1" colspan="1">Up in serum</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">LRG1 was significantly upregulated in the serum of patients with sepsis-associated AKI than those without sepsis (<em>p</em>
<span style="color:#FE0191">&#x0003c;</span> 0.05). LRG1 might be a novel substance associated with sepsis</td></tr><tr><td rowspan="1" colspan="1">Lee et al. [<a href="#B46" rid="B46" class=" bibr popnode">46</a>] (2018)</td><td rowspan="1" colspan="1">Cells and mice</td><td rowspan="1" colspan="1">Proteinuria-induced renal tubular injury (intraperitoneal injection of pH 7.0 and low-endotoxin bovine serum albumin)</td><td rowspan="1" colspan="1">Up in urine</td><td rowspan="1" colspan="1">Activated NLRP3-IL-1b pathway</td><td rowspan="1" colspan="1">Urinary LRG was produced in renal TECs, which released during proteinuria-induced renal damage. LRG could be blocked by IL-1 receptor antagonist</td></tr><tr><td rowspan="1" colspan="1">Jiang et al. [<a href="#B43" rid="B43" class=" bibr popnode">43</a>] (2020)</td><td rowspan="1" colspan="1">Patients (<em>n</em> = 60)</td><td rowspan="1" colspan="1">Cisplatin-induced AKI</td><td rowspan="1" colspan="1">Up in kidney tissue and urine</td><td rowspan="1" colspan="1">GDF15 and SPP1</td><td rowspan="1" colspan="1">LRG1 might be one of the candidate urinary markers of kidney injury after cisplatin treatment. LRG1, combined with GDF15 and SPP1, involved in the development of cisplatin-induced kidney injury</td></tr><tr><td rowspan="1" colspan="1">Muk et al. [<a href="#B49" rid="B49" class=" bibr popnode">49</a>] (2020)</td><td rowspan="1" colspan="1">Mouse, cells, and patients</td><td rowspan="1" colspan="1">Chorioamnionitis-induced kidney injury</td><td rowspan="1" colspan="1">Up in the kidney tissues</td><td rowspan="1" colspan="1">HIF-1&#x003b1; activation</td><td rowspan="1" colspan="1">Both mRNA and protein levels of LRG1 were elevated in the kidneys of lipopolysaccharide pigs at birth and associated with plasma creatinine. Kidney injury might be caused by LRG1-mediated hypoxia via HIF-1&#x003b1; activation</td></tr><tr><td rowspan="1" colspan="1">Popova et al. [<a href="#B45" rid="B45" class=" bibr popnode">45</a>] (2022)</td><td rowspan="1" colspan="1">Patients (<em>n</em> = 35)</td><td rowspan="1" colspan="1">Kidney injury induced by kidney transplant</td><td rowspan="1" colspan="1">Up in serum and urine</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">Upregulation of serum and urine LRG1 were significantly correlated to kidney transplant injury and functional deterioration</td></tr></tbody></table></div><div class="largeobj-link align_right" id="largeobj_idm140470075644592"><a target="object" rel="noopener" href="/pmc/articles/PMC11126829/table/T2/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="fn-a.h.d.c.d.a"><p class="p p-first-last">eGFR, estimated glomerular filtration rate; AKI, acute kidney injury; CKD, chronic kidney disease.</p></div></div></div><p>In one of the three clinical studies, Hashida et al. [<a href="#B40" rid="B40" class=" bibr popnode">40</a>] reported that LRG1 was significantly upregulated in the serum of patients with sepsis-induced AKI than those without sepsis (sample size, <em>p</em> &#x0003c; 0.05). Sepsis is a life-threatening condition induced by dysregulated host responses to infection [<a href="#B41" rid="B41" class=" bibr popnode">41</a>]. Proteome analysis on plasma has been found to be a novel biomarker for diagnosing with sepsis. In the study by Hashida et al., the authors identified 400 proteins from the plasma in AKI patients with sepsis and concluded that LRG1 might be a novel substance associated with sepsis and sepsis-induced AKI. Cisplatin is one of the common and effective treatments for various types of cancers, but the complications of nephrotoxicity limit its use [<a href="#B42" rid="B42" class=" bibr popnode">42</a>]. Jiang et al. [<a href="#B43" rid="B43" class=" bibr popnode">43</a>] suggested that LRG1 was elevated in the renal tissues and urine of patients with cisplatin-induced kidney injury. They implicated that LRG1 might be one of the candidate urinary markers of kidney injury after cisplatin treatment. LRG1, combined with GDF15 and SPP1, involved in the development of cisplatin-induced kidney injury. This study may help design the new methods to monitor the kidney function in cisplatin-based chemotherapy. Kidney transplantation is an efficient therapy for patients with end-stage renal disease, but transplantation-associated kidney injury is a non-negligible issue [<a href="#B44" rid="B44" class=" bibr popnode">44</a>]. As aforementioned, LRG1 has been found to serve as an effective biomarker of kidney injury. In line with above findings, Popova et al. [<a href="#B45" rid="B45" class=" bibr popnode">45</a>] also reported LRG1 was up in serum and urine of patients with kidney injury induced by kidney transplant (<em>n</em> = 35). A positive correlation was found between serum and urine LRG1 (<em>r</em> = 0.41; 95% CI: 0.09 to 0.66; <em>p</em> = 0.01). The aforementioned three clinical studies have provided evidence regarding the significance of serum, urine, and renal tissue LRG1 as a marker for kidney injury in sepsis, chemotherapy, and kidney transplant.</p><p class="p p-last">There were two in vitro and in vivo study reported biological effects of LRG1 in kidney injury. Lee et al. [<a href="#B46" rid="B46" class=" bibr popnode">46</a>] established the cellular and mice models of renal tubular injury. They found that urinary LRG was produced in renal TECs, which released during proteinuria-induced renal damage. LRG could be blocked by interleukin-1 (IL-1) receptor antagonist. LRG played its roles in renal cell injury by activating NLRP3-IL-1b pathway. LRG expression can be induced by inflammatory cytokines, including IL-6, IL-1b, and tumor necrosis factor-&#x003b1; (TNF&#x003b1;) [<a href="#B47" rid="B47" class=" bibr popnode">47</a>]. LRG protein levels are elevated not only in serum but also in secreted materials from the inflamed tissues [<a href="#B48" rid="B48" class=" bibr popnode">48</a>]. The study by Lee et al. [<a href="#B46" rid="B46" class=" bibr popnode">46</a>] suggested that urinary LRG might be a potential biomarker for renal tubule injury and the interstitial inflammation in renal diseases. Another study developed by Muk et al. [<a href="#B49" rid="B49" class=" bibr popnode">49</a>] demonstrated that both mRNA and protein levels of LRG1 were elevated in the kidneys of lipopolysaccharide pigs (chorioamnionitis-induced kidney injury) at birth and associated with plasma creatinine. Additionally, exposure to prenatal endotoxins may result in renal inflammation during fetal and postnatal stages, potentially leading to kidney injury through LRG1-mediated hypoxia via HIF-1&#x003b1; activation. Lee et al. [<a href="#B46" rid="B46" class=" bibr popnode">46</a>] reported that pro-inflammatory cytokine production (i.e., IL-1&#x003b2;) during renal tubular injury might be the major mechanism to increase urinary LRG. IL-1&#x003b2; induces LRG expression in renal tubular cells and LRG excretion in urine. In line with this finding, Muk et al. [<a href="#B49" rid="B49" class=" bibr popnode">49</a>] implied that upregulated LRG1 expression was associated with renal inflammation, hypoxia, and immune cell infiltration during the process of AKI. Therefore, the possible pathophysiological mechanisms linking LRG1 upregulation and AKI might be closely correlated to its effects on renal inflammation. These two experimental studies have further illustrated the potential of LRG1 as a diagnostic and therapeutic target for kidney injury associated with inflammation. However, the underlying mechanisms of this primary glomerulonephritis remain uncertain at present.</p></div><div id="s1-4" class="tsec sec"><h2 class="head no_bottom_margin" id="s1-4title">IgA Nephropathy</h2><p class="p p-first-last">IgA nephropathy (IgAN) is an inflammatory and immune-associated CKD [<a href="#B50" rid="B50" class=" bibr popnode">50</a>]. In this review, three clinical studies reported the expression of LRG1 in patients with IgAN. Khositseth et al. [<a href="#B51" rid="B51" class=" bibr popnode">51</a>] conducted a case reported study with a case of IgAN associated with Hodgkin&#x02019;s disease in a child. The LRG1 expression (1.4343) in the urinary was high (up in urine) before treatments with CHOP chemotherapy and enalapril, while LRG1 decreased after 1 month (0.7459) and 4 months (0.3757) of treatments. Khositseth et al. suggested that proteomic technology for detecting LRG1 expression might effectively monitor therapeutic response of IgAN. Consistent with the study by Khositseth et al., a recent clinical study developed by Liu et al. [<a href="#B52" rid="B52" class=" bibr popnode">52</a>] also demonstrated that LRG1 expression was elevated in patients with IgAN than the controls. The expression of LRG1 level was increased in renal tissues of IgAN patients with heavy fibrosis and heavy inflammatory cell infiltration. The authors implicated that LRG1 inhibited fibronectin secretion by suppressing TGF-&#x003b2;1 expression. TGF-&#x003b2;1 was found to serve as an important factor to produce pro-fibrotic proteins [<a href="#B53" rid="B53" class=" bibr popnode">53</a>]. Renal interstitial fibrosis may cause by the actions of TGF-&#x003b2;1 on renal TECs and endothelial cells. Of note, the findings by Kalantari et al. [<a href="#B54" rid="B54" class=" bibr popnode">54</a>] are incongruent with the above two included studies. The authors evidenced that LRG1 expression was low in the urinary of patients with IgAN. There was a positive association between LRG1 expression and the value of eGFR (<em>p</em> &#x0003c; 0.001). Furthermore, the expression of LRG1 was found to be linked to the differentiation of brown fat cells. However, the inconsistent findings in this regard remain unclear. It is postulated that the involvement of different races and study populations may contribute to this phenomenon.</p></div><div id="s1-5" class="tsec sec"><h2 class="head no_bottom_margin" id="s1-5title">Chronic Kidney Disease</h2><p class="p p-first-last">CKD, ranked as the 10th leading cause of mortality, affects a substantial proportion of the global population, reaching up to 13% [<a href="#B55" rid="B55" class=" bibr popnode">55</a>]. The identification of accurate biomarkers for early diagnosing of CKD is a real challenge. Within the topic of this review, we identified two large-sample clinical studies reported the roles of LRG1 in the development of CKD. Both of two studies indicated the level of LRG1 was upregulated in serum of plasma of the patients with CKD. Liu et al. [<a href="#B16" rid="B16" class=" bibr popnode">16</a>] recruited 1,226 patients with CKD and found that patients with albuminuria progression and CKD progression had higher plasma LRG1 levels at baseline. LRG1 independently predicted both albuminuria progression and CKD progression above traditional risk factors (i.e., eGFR and urine albumin-to-creatinine ratio). In line with this study, Low et al. [<a href="#B56" rid="B56" class=" bibr popnode">56</a>] showed that increase in skeletal muscle mass ameliorated the effect of pigment epithelium-derived factor (PEDF) and LRG1 on CKD progression. PEDF, a secreted glycoprotein from the serpin family, has been confirmed to function as an anti-inflammatory, antioxidant, and anti-angiogenic factor [<a href="#B57" rid="B57" class=" bibr popnode">57</a>]. PEDF has emerged as a novel biomarker with potential implications in renal decline, particularly in chronic kidney disease (CKD) [<a href="#B58" rid="B58" class=" bibr popnode">58</a>]. Within the kidney, PEDF may confer reno-protection by mitigating fibrosis, inflammation, vascular hyper-permeability, and podocytes renal cell apoptosis induced by advanced glycation end products [<a href="#B59" rid="B59" class=" bibr popnode">59</a>]. Conversely, plasma levels of PEDF may rise as a compensatory mechanism for diminished kidney-specific PEDF levels. A previous study [<a href="#B60" rid="B60" class=" bibr popnode">60</a>] demonstrated decreased PEDF expression in the kidneys of streptozotocin-induced diabetic rats compared to nondiabetic rats. At present, only one clinical study [<a href="#B56" rid="B56" class=" bibr popnode">56</a>] reported the roles of PEDF and LRG1 in CKD development. The authors found that plasma PEDF and LRG1 mediated the negative association between higher skeletal muscle mass index and CKD progression, which might be driven by inflammation. Given that PEDF is synthesized by a variety of cell types including hepatocytes, adipocytes, and muscle cells, while LRG1 is primarily synthesized by the liver, it is conceivable that dysfunctional adipocytes or hepatocytes could potentially lead to a systemic increase in inflammatory activity, as evidenced by elevated levels of plasma PEDF and LRG1, thereby contributing to the progression of CKD. Collectively, the concurrent involvement of PEDF and LRG1 in CKD progression may be attributed to their ability to enhance the inflammatory response. The aforementioned studies provided evidence indicating that elevated levels of plasma LRG1 are associated with the progression of CKD.</p></div><div id="s1-6" class="tsec sec"><h2 class="head no_bottom_margin" id="s1-6title">Other Types of Kidney Diseases</h2><p class="p p-first">Moreover, within the scope of this subject, we also identified six additional studies that reported on the correlation between LRG1 expression and various other kidney diseases (<a href="/pmc/articles/PMC11126829/table/T3/" target="table" class="fig-table-link figpopup" rid-figpopup="T3" rid-ob="ob-T3" co-legend-rid=""><span>Table 3</span></a>). Hong et al. [<a href="#B61" rid="B61" class=" bibr popnode">61</a>] evidenced that LRG1 was upregulated in kidney tissue samples of clear cell renal cell carcinoma (ccRCC) patients (<em>n</em> = 528). The methylation level of LRG1 was dramatically declined in ccRCC. LRG1 was negatively associated with the survival of ccRCC patients. LRG1 might promote ccRCC progression via the TGF-&#x003b2; pathway. LRG1 was found to express in plasma, leukocytes, proximal tubule, and inflammatory cells [<a href="#B62" rid="B62" class=" bibr popnode">62</a>]. It upregulated in the plasma, peripheral blood leukocytes, and kidney of patients with lupus nephritis (sample size: 101). LRG1 suppressed the late apoptosis, promoted proliferation, and regulated the expression of both inflammatory factors and cytokines [<a href="#B62" rid="B62" class=" bibr popnode">62</a>]. Yang et al. [<a href="#B63" rid="B63" class=" bibr popnode">63</a>] investigated the roles of LRG1 in patients with ESKD (<em>n</em> = 169). The authors found that LRG1 was up in plasma of ESKD patients. LRG1 expression was significantly associated with the presence of peripheral arterial occlusive disease and cardiovascular disease in patients with ESKD. LRG1 level positively was correlated to IL-6, hsCRP, and advanced T-cell differentiation. In a dog model of canine leishmaniosis-induced kidney disease, Gonzalez et al. [<a href="#B64" rid="B64" class=" bibr popnode">64</a>] implicated that LRG1 was elevated in urinary expression. LRG1 was one of the 12 discriminant variables found in dogs with renal disease induced by leishmaniosis. Hong et al. [<a href="#B65" rid="B65" class=" bibr popnode">65</a>] showed that high level LRG1 in renal tissues cells might be correlated to the progression of kidney fibrosis. They also indicated that LRG1 might serve as an important amplifier of tubulointerstitial TGF-&#x003b2;/Smad3 signal transduction that enhanced renal fibrosis in CKD. Thus, suppression of LRG1 effectively reduced TGF-&#x003b2; signaling. Consistently, Jiang et al. [<a href="#B66" rid="B66" class=" bibr popnode">66</a>] showed that LRG1 was upregulated in the renal tissues as well as the cells in an experimental model mimicked aristolochic acid nephropathy. LRG1-enriched extracellular vesicles induced the injury and apoptosis of TECs and apoptosis via a TGF-&#x003b2;R1-dependent process. In agreement, the above six included studies demonstrated that LRG1 was significantly increased in the plasma, urine, renal tissues and cells, either in animal or human. Activation of TGF-&#x003b2;, TGF-&#x003b2;R1, and their associated genes of pathways played an essential role in this action.</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap anchored whole_rhythm" id="T3"><h3>Table 3.</h3><!--caption a7--><div class="caption"><p>Role of LRG1 in other kidney diseases</p></div><div class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th rowspan="1" colspan="1">Study/reference</th><th rowspan="1" colspan="1">Study objects</th><th rowspan="1" colspan="1">Kidney disease</th><th rowspan="1" colspan="1">LRG1 expression</th><th rowspan="1" colspan="1">Associated genes or pathways</th><th rowspan="1" colspan="1">Main findings</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Khositseth et al. [<a href="#B51" rid="B51" class=" bibr popnode">51</a>] (2007)</td><td rowspan="1" colspan="1">Patients (<em>n</em> = 1)</td><td rowspan="1" colspan="1">IgAN</td><td rowspan="1" colspan="1">Up in urine</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">A case of IgAN associated with Hodgkin&#x02019;s disease in a child. The LRG1 expression (1.4343) in the urinary was high before treatments with CHOP chemotherapy and enalapril, while LRG1 decreased after 1 month (0.7459) and 4 months (0.3757) of treatments</td></tr><tr><td rowspan="1" colspan="1">Kalantari et al. [<a href="#B54" rid="B54" class=" bibr popnode">54</a>] (2013)</td><td rowspan="1" colspan="1">Patients (<em>n</em> = 13)</td><td rowspan="1" colspan="1">IgA nephropathy</td><td rowspan="1" colspan="1">Down in urine</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">LRG1 expression was low in the urinary of patients with IgAN. There was a positive association between LRG1 expression and the value of eGFR (<em>p</em>
<span style="color:#FE0191">&#x0003c;</span> 0.001). LRG1 expression was associated with the brown fat cell differentiation</td></tr><tr><td rowspan="1" colspan="1">Liu et al. [<a href="#B52" rid="B52" class=" bibr popnode">52</a>] (2021)</td><td rowspan="1" colspan="1">Patients (<em>n</em> = 141)</td><td rowspan="1" colspan="1">IgAN</td><td rowspan="1" colspan="1">Up in plasma and renal tissues</td><td rowspan="1" colspan="1">Inhibited TGF-&#x003b2;1</td><td rowspan="1" colspan="1">The expression of LRG1 level increased in renal tissues of IgAN patients with heavy fibrosis and heavy inflammatory cell infiltration. LRG1 expression was also elevated in patients with IgAN than the controls. LRG1 inhibited fibronectin secretion by suppressing TGF-&#x003b2;1 expression</td></tr><tr><td rowspan="1" colspan="1">Liu et al. [<a href="#B16" rid="B16" class=" bibr popnode">16</a>] (2017)</td><td rowspan="1" colspan="1">Patients (<em>n</em> = 1,226)</td><td rowspan="1" colspan="1">CKD (inclusion criteria: adult patients who aged 21 years and older with type 2 diabetes)</td><td rowspan="1" colspan="1">Up in serum</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">Patients with albuminuria progression and CKD progression had higher plasma LRG1 levels at baseline. LRG1 independently predicted both albuminuria progression and CKD progression above traditional risk factors (i.e., eGFR and urine albumin-to-creatinine ratio)</td></tr><tr><td rowspan="1" colspan="1">Low et al. [<a href="#B56" rid="B56" class=" bibr popnode">56</a>] (2021)</td><td rowspan="1" colspan="1">Patients (<em>n</em> = 1,272)</td><td rowspan="1" colspan="1">CKD (inclusion criteria: patients with type 2 diabetes, having greater than two eGFR readings and more than 1 year of follow-up)</td><td rowspan="1" colspan="1">Up in plasma</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">Increase in skeletal muscle mass ameliorated the effect of pigment epithelium-derived factor (PEDF) and LRG1 on CKD progression</td></tr><tr><td rowspan="1" colspan="1">Hong et al. [<a href="#B61" rid="B61" class=" bibr popnode">61</a>] (2020)</td><td rowspan="1" colspan="1">Patients (<em>n</em> = 528)</td><td rowspan="1" colspan="1">ccRCC</td><td rowspan="1" colspan="1">Up in ccRCC kidney tissue</td><td rowspan="1" colspan="1">Activated TGF-&#x003b2; pathway</td><td rowspan="1" colspan="1">LRG1 upregulated in ccRCC kidney tissue samples. The methylation level of LRG1 was dramatically declined in ccRCC. LRG1 was negatively associated with the survival of ccRCC patients. LRG1 might promote ccRCC progression via the TGF-&#x003b2; pathway</td></tr><tr><td rowspan="1" colspan="1">Yang et al. [<a href="#B62" rid="B62" class=" bibr popnode">62</a>] (2020)</td><td rowspan="1" colspan="1">Patients (<em>n</em> = 101)</td><td rowspan="1" colspan="1">Lupus nephritis</td><td rowspan="1" colspan="1">Up in plasma and kidney</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">LRG1 was found to express in plasma, leukocytes, proximal tubule, and inflammatory cells. It upregulated in the plasma, peripheral blood leukocytes, and kidney of patients with lupus nephritis. LRG1 suppressed the late apoptosis, promoted proliferation, and regulated the expression of both inflammatory factors and cytokines</td></tr><tr><td rowspan="1" colspan="1">Yang et al. [<a href="#B63" rid="B63" class=" bibr popnode">63</a>] (2020)</td><td rowspan="1" colspan="1">Patients (<em>n</em> = 169)</td><td rowspan="1" colspan="1">End-stage kidney disease (ESKD)</td><td rowspan="1" colspan="1">Up in plasma</td><td rowspan="1" colspan="1">IL-6 and hsCRP</td><td rowspan="1" colspan="1">LRG1 expression was significantly associated with the presence of peripheral arterial occlusive disease and cardiovascular disease in patients with ESKD. LRG1 level positively correlated to IL-6, hsCRP, and advanced T-cell differentiation</td></tr><tr><td rowspan="1" colspan="1">Gonzalez et al. [<a href="#B64" rid="B64" class=" bibr popnode">64</a>] (2022)</td><td rowspan="1" colspan="1">Dogs</td><td rowspan="1" colspan="1">Canine leishmaniosis-induced kidney disease</td><td rowspan="1" colspan="1">Up in urinary expression</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">LRG1 was one of the 12 discriminant variables found in dogs with renal disease induced by leishmaniosis</td></tr><tr><td rowspan="1" colspan="1">Hong et al. [<a href="#B65" rid="B65" class=" bibr popnode">65</a>] (2022)</td><td rowspan="1" colspan="1">Cells and mice</td><td rowspan="1" colspan="1">Kidney fibrosis</td><td rowspan="1" colspan="1">Up in renal tissues</td><td rowspan="1" colspan="1">Activated TGF-&#x003b2;/Smad3</td><td rowspan="1" colspan="1">LRG1 served as an important amplifier of tubulointerstitial TGF-&#x003b2;/Smad3 signal transduction that enhanced renal fibrosis in CKD. Suppression of LRG1 effectively reduced TGF-&#x003b2; signaling</td></tr><tr><td rowspan="1" colspan="1">Jiang et al. [<a href="#B66" rid="B66" class=" bibr popnode">66</a>] (2022)</td><td rowspan="1" colspan="1">Cells and mice</td><td rowspan="1" colspan="1">Aristolochic acid nephropathy</td><td rowspan="1" colspan="1">Up in renal tissues and cells</td><td rowspan="1" colspan="1">Activated TGF-&#x003b2;R1</td><td rowspan="1" colspan="1">LRG1-enriched extracellular vesicles induced the injury and apoptosis of TECs and apoptosis via a TGF-&#x003b2;R1-dependent process</td></tr></tbody></table></div><div class="largeobj-link align_right" id="largeobj_idm140470075557328"><a target="object" rel="noopener" href="/pmc/articles/PMC11126829/table/T3/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="fn-a.h.g.c.d.a"><p class="p p-first-last">eGFR, estimated glomerular filtration rate; AKI, acute kidney injury; CKD, chronic kidney disease.</p></div></div></div></div><div id="s2" class="tsec sec"><h2 class="head no_bottom_margin" id="s2title">Conclusion and Perspectives</h2><p class="p p-first">This review highlights the crucial functions of LRG1 on the pathogenesis of diverse kidney diseases. LRG1 was commonly upregulated in kidney diseases, including diabetic nephropathy, kidney injury, IgAN, CKD, ccRCC, end-stage renal disease, canine leishmaniosis-induced kidney disease, kidney fibrosis, and aristolochic acid nephropathy. A study [<a href="#B37" rid="B37" class=" bibr popnode">37</a>] indicated that metformin protected against diabetic nephropathy. The nephroprotective effect of metformin was speculated to mediate by downregulating of LRG1 and TGF-&#x003b2;1/ALK1-induced renal angiogenesis. This review highlighted that overactivation of LRG1 has been associated with the development of various kidney diseases, while inhibition of LRG1 expression significantly prevented these diseases. Therefore, future drugs or therapy-targeted LRG1 may provide a promising therapeutic direction against multiple kidney diseases. Further preclinical and clinical studies are warranted to investigate the effectiveness and safety of LRG1 inhibitors for treating kidney diseases.</p><p class="p">As shown in <a href="/pmc/articles/PMC11126829/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Figure 1</span></a>, LRG1 exerts a deleterious influence on kidney diseases by regulating multiple associated genes and signaling cascades, i.e., fibronectin 1, GPR56, VEGF, VEGFR-2, DR5, GDF15, HIF-1&#x003b1;, SPP1, ALK1-Smad1/5/8, NLRP3-IL-1b, and TGF-&#x003b2; pathway. Through comprehensive and thorough investigations in the future, the intricate molecular mechanisms underlying LRG1 in the development and pathophysiology of kidney diseases will be comprehensively elucidated. Consequently, therapeutic interventions targeting LRG1 are anticipated to be implemented in clinical trials and subsequently incorporated into clinical practice.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="F1" co-legend-rid="lgnd_F1"><a href="/pmc/articles/PMC11126829/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140470075475184"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=11126829_kdd-2024-0010-0003-538443_f01.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is kdd-2024-0010-0003-538443_f01.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC11126829/bin/kdd-2024-0010-0003-538443_f01.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140470075475184"><a target="object" rel="noopener" href="/pmc/articles/PMC11126829/figure/F1/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F1"><div><a class="figpopup" href="/pmc/articles/PMC11126829/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1">Fig. 1.</a></div><!--caption a7--><div class="caption"><p>Molecular mechanisms underlying the roles of LRG1 on the development of various types of kidney diseases.</p></div></div></div></div><div id="s3" class="tsec sec"><h2 class="head no_bottom_margin" id="s3title">Conflict of Interest Statement</h2><p class="p p-first-last">The authors declare that they have no competing interests.</p></div><div id="s4" class="tsec sec"><h2 class="head no_bottom_margin" id="s4title">Funding Sources</h2><p class="p p-first-last">This study was supported by the Health Science and Technology Project of Guangzhou City, Guangdong Province (Grant No. 20231A011015, for Jingwei Zhang).</p></div><div id="s5" class="tsec sec"><h2 class="head no_bottom_margin" id="s5title">Author Contributions</h2><p class="p p-first-last">C.Y.C., J.W.Z., and T.Y. contributed to conceive and design the study. J.L. and H.Y.F. performed the systematic searching. C.Y.C. and T.Y. extracted the data. H.Y.F. wrote the manuscript. C.Y.C. supervised the manuscript. Y.F.J. contributed to the revision of the manuscript. All of the authors read and approved the final manuscript.</p></div><div id="funding-group-a.g.b.q" class="tsec sec"><h2 class="head no_bottom_margin" id="funding-group-a.g.b.qtitle">Funding Statement</h2><p>This study was supported by the Health Science and Technology Project of Guangzhou City, Guangdong Province (Grant No. 20231A011015, for Jingwei Zhang).</p></div><div id="ref-list-a.i.a" class="tsec sec"><h2 class="head no_bottom_margin" id="ref-list-a.i.atitle">References</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="B1">1. <span class="mixed-citation">Glassock RJ, Warnock DG, Delanaye P. <span class="ref-title">The global burden of chronic kidney disease: estimates, variability and pitfalls</span>. <span class="ref-journal">Nat Rev Nephrol</span>. 2017;<span class="ref-vol">13</span>(<span class="ref-iss">2</span>):104&#x02013;14.
 [<a href="https://pubmed.ncbi.nlm.nih.gov/27941934" ref="reftype=pubmed&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Rev+Nephrol&amp;title=The+global+burden+of+chronic+kidney+disease:+estimates,+variability+and+pitfalls&amp;volume=13&amp;issue=2&amp;publication_year=2017&amp;pages=104-14&amp;pmid=27941934&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B2">2. <span class="mixed-citation">Kamt SF, Liu J, Yan LJ. <span class="ref-title">Renal-protective roles of lipoic acid in kidney disease</span>. <span class="ref-journal">Nutrients</span>. 2023;<span class="ref-vol">15</span>(<span class="ref-iss">7</span>):1732.
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC10097220/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/37049574" ref="reftype=pubmed&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nutrients&amp;title=Renal-protective+roles+of+lipoic+acid+in+kidney+disease&amp;volume=15&amp;issue=7&amp;publication_year=2023&amp;pages=1732&amp;pmid=37049574&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B3">3. <span class="mixed-citation">Turgut F, Somfai GM, Heussen FM, Eberle A, de Smet MD, Becker MD. <span class="ref-title">Robot-assisted epiretinal membrane peeling: a prospective assessment of pre- and intra-operative times and of surgeons' subjective perceptions</span>. <span class="ref-journal">J Clin Med</span>. 2023;<span class="ref-vol">12</span>(<span class="ref-iss">8</span>):2768.
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC10141075/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/37109104" ref="reftype=pubmed&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Med&amp;title=Robot-assisted+epiretinal+membrane+peeling:+a+prospective+assessment+of+pre-+and+intra-operative+times+and+of+surgeons'+subjective+perceptions&amp;volume=12&amp;issue=8&amp;publication_year=2023&amp;pages=2768&amp;pmid=37109104&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B4">4. <span class="mixed-citation">Roberts N, Pierre JL, Rouzier V, Sufra R, St-Preux S, Yan LD, et al.. <span class="ref-title">Prevalence and severity of chronic kidney disease in Haiti</span>. <span class="ref-journal">Clin J Am Soc Nephrol</span>. 2023;<span class="ref-vol">18</span>(<span class="ref-iss">6</span>):739&#x02013;47.
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC10278829/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/37081617" ref="reftype=pubmed&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+J+Am+Soc+Nephrol&amp;title=Prevalence+and+severity+of+chronic+kidney+disease+in+Haiti&amp;volume=18&amp;issue=6&amp;publication_year=2023&amp;pages=739-47&amp;pmid=37081617&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B5">5. <span class="mixed-citation">Sanz AB, Sanchez-Nino MD, Ramos AM, Ortiz A. <span class="ref-title">Regulated cell death pathways in kidney disease</span>. <span class="ref-journal">Nat Rev Nephrol</span>. 2023;<span class="ref-vol">19</span>(<span class="ref-iss">5</span>):281&#x02013;99.
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC10035496/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/36959481" ref="reftype=pubmed&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Rev+Nephrol&amp;title=Regulated+cell+death+pathways+in+kidney+disease&amp;volume=19&amp;issue=5&amp;publication_year=2023&amp;pages=281-99&amp;pmid=36959481&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B6">6. <span class="mixed-citation">Beaubien-Souligny W, Trott T, Neyra JA. <span class="ref-title">How to determine fluid management goals during continuous kidney replacement therapy in patients with AKI: focus on POCUS</span>. <span class="ref-journal">Kidney360</span>. 2022;<span class="ref-vol">3</span>(<span class="ref-iss">10</span>):1795&#x02013;806.
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC9717662/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/36514727" ref="reftype=pubmed&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Kidney360&amp;title=How+to+determine+fluid+management+goals+during+continuous+kidney+replacement+therapy+in+patients+with+AKI:+focus+on+POCUS&amp;volume=3&amp;issue=10&amp;publication_year=2022&amp;pages=1795-806&amp;pmid=36514727&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B7">7. <span class="mixed-citation">Nishioka N, Luo Y, Taniguchi T, Ohnishi T, Kimachi M, Ng RC, et al.. <span class="ref-title">Carnitine supplements for people with chronic kidney disease requiring dialysis</span>. <span class="ref-journal">Cochrane Database Syst Rev</span>. 2022;<span class="ref-vol">12</span>:CD013601.
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC9724937/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/36472884" ref="reftype=pubmed&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cochrane+Database+Syst+Rev&amp;title=Carnitine+supplements+for+people+with+chronic+kidney+disease+requiring+dialysis&amp;volume=12&amp;publication_year=2022&amp;pages=CD013601&amp;pmid=36472884&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B8">8. <span class="mixed-citation">Levey AS, Becker C, Inker LA. <span class="ref-title">Glomerular filtration rate and albuminuria for detection and staging of acute and chronic kidney disease in adults: a systematic review</span>. <span class="ref-journal">JAMA</span>. 2015;<span class="ref-vol">313</span>(<span class="ref-iss">8</span>):837&#x02013;46.
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4410363/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/25710660" ref="reftype=pubmed&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=JAMA&amp;title=Glomerular+filtration+rate+and+albuminuria+for+detection+and+staging+of+acute+and+chronic+kidney+disease+in+adults:+a+systematic+review&amp;volume=313&amp;issue=8&amp;publication_year=2015&amp;pages=837-46&amp;pmid=25710660&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B9">9. <span class="mixed-citation">Petrazzuolo A, Sabiu G, Assi E, Maestroni A, Pastore I, Lunati ME, et al.. <span class="ref-title">Broadening horizons in mechanisms, management, and treatment of diabetic kidney disease</span>. <span class="ref-journal">Pharmacol Res</span>. 2023;<span class="ref-vol">190</span>:106710.
 [<a href="https://pubmed.ncbi.nlm.nih.gov/36871895" ref="reftype=pubmed&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Pharmacol+Res&amp;title=Broadening+horizons+in+mechanisms,+management,+and+treatment+of+diabetic+kidney+disease&amp;volume=190&amp;publication_year=2023&amp;pages=106710&amp;pmid=36871895&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B10">10. <span class="mixed-citation">Zou Y, Xu Y, Chen X, Wu Y, Fu L, Lv Y. <span class="ref-title">Research progress on leucine-rich alpha-2 glycoprotein 1: a review</span>. <span class="ref-journal">Front Pharmacol</span>. 2021;<span class="ref-vol">12</span>:809225.
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC8797156/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/35095520" ref="reftype=pubmed&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Front+Pharmacol&amp;title=Research+progress+on+leucine-rich+alpha-2+glycoprotein+1:+a+review&amp;volume=12&amp;publication_year=2021&amp;pages=809225&amp;pmid=35095520&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B11">11. <span class="mixed-citation">Wang X, Abraham S, McKenzie J, Jeffs N, Swire M, Tripathi VB, et al.. <span class="ref-title">LRG1 promotes angiogenesis by modulating endothelial TGF-&#x003b2; signalling</span>. <span class="ref-journal">Nature</span>. 2013;<span class="ref-vol">499</span>(<span class="ref-iss">7458</span>):306&#x02013;11.
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3836402/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/23868260" ref="reftype=pubmed&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=LRG1+promotes+angiogenesis+by+modulating+endothelial+TGF-&#x003b2;+signalling&amp;volume=499&amp;issue=7458&amp;publication_year=2013&amp;pages=306-11&amp;pmid=23868260&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B12">12. <span class="mixed-citation">He L, Wei Q, Liu J, Yi M, Liu Y, Liu H, et al.. <span class="ref-title">AKI on CKD: heightened injury, suppressed repair, and the underlying mechanisms</span>. <span class="ref-journal">Kidney Int</span>. 2017;<span class="ref-vol">92</span>(<span class="ref-iss">5</span>):1071&#x02013;83.
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5683166/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/28890325" ref="reftype=pubmed&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Kidney+Int&amp;title=AKI+on+CKD:+heightened+injury,+suppressed+repair,+and+the+underlying+mechanisms&amp;volume=92&amp;issue=5&amp;publication_year=2017&amp;pages=1071-83&amp;pmid=28890325&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B13">13. <span class="mixed-citation">Park CH, Yoo TH. <span class="ref-title">TGF-&#x00392; inhibitors for therapeutic management of kidney fibrosis</span>. <span class="ref-journal">Pharmaceuticals</span>. 2022;<span class="ref-vol">15</span>(<span class="ref-iss">12</span>):1485.
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC9783223/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/36558936" ref="reftype=pubmed&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Pharmaceuticals&amp;title=TGF-&#x00392;+inhibitors+for+therapeutic+management+of+kidney+fibrosis&amp;volume=15&amp;issue=12&amp;publication_year=2022&amp;pages=1485&amp;pmid=36558936&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B14">14. <span class="mixed-citation">Tanabe K, Wada J, Sato Y. <span class="ref-title">Targeting angiogenesis and lymphangiogenesis in kidney disease</span>. <span class="ref-journal">Nat Rev Nephrol</span>. 2020;<span class="ref-vol">16</span>(<span class="ref-iss">5</span>):289&#x02013;303.
 [<a href="https://pubmed.ncbi.nlm.nih.gov/32144398" ref="reftype=pubmed&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Rev+Nephrol&amp;title=Targeting+angiogenesis+and+lymphangiogenesis+in+kidney+disease&amp;volume=16&amp;issue=5&amp;publication_year=2020&amp;pages=289-303&amp;pmid=32144398&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B15">15. <span class="mixed-citation">Haupt H, Baudner S. <span class="ref-title">Isolierung und Charakterisierung eines bisher unbekannten leucinreichen 3.1S-&#x003b1;<sub>2</sub>-Glykoproteins aus Humanserum</span>. <span class="ref-journal">Hoppe Seylers Z Physiol Chem</span>. 1977;<span class="ref-vol">358</span>(<span class="ref-iss">1</span>):639&#x02013;46.
 [<a href="https://pubmed.ncbi.nlm.nih.gov/69600" ref="reftype=pubmed&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Hoppe+Seylers+Z+Physiol+Chem&amp;title=Isolierung+und+Charakterisierung+eines+bisher+unbekannten+leucinreichen+3.1S-&#x003b1;2-Glykoproteins+aus+Humanserum&amp;volume=358&amp;issue=1&amp;publication_year=1977&amp;pages=639-46&amp;pmid=69600&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B16">16. <span class="mixed-citation">Liu JJ, Pek S, Ang K, Tavintharan S, Lim SC, SMART2D study . <span class="ref-title">Plasma leucine-rich &#x003b1;-2-glycoprotein 1 predicts rapid eGFR decline and albuminuria progression in type 2 diabetes mellitus</span>. <span class="ref-journal">J Clin Endocrinol Metab</span>. 2017;<span class="ref-vol">102</span>(<span class="ref-iss">10</span>):3683&#x02013;91.
 [<a href="https://pubmed.ncbi.nlm.nih.gov/28973352" ref="reftype=pubmed&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Endocrinol+Metab&amp;title=Plasma+leucine-rich+&#x003b1;-2-glycoprotein+1+predicts+rapid+eGFR+decline+and+albuminuria+progression+in+type+2+diabetes+mellitus&amp;volume=102&amp;issue=10&amp;publication_year=2017&amp;pages=3683-91&amp;pmid=28973352&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B17">17. <span class="mixed-citation">Takahashi N, Takahashi Y, Putnam FW. <span class="ref-title">Periodicity of leucine and tandem repetition of a 24-amino acid segment in the primary structure of leucine-rich alpha 2-glycoprotein of human serum</span>. <span class="ref-journal">Proc Natl Acad Sci U S A</span>. 1985;<span class="ref-vol">82</span>(<span class="ref-iss">7</span>):1906&#x02013;10.
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC397442/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/3856868" ref="reftype=pubmed&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+U+S+A&amp;title=Periodicity+of+leucine+and+tandem+repetition+of+a+24-amino+acid+segment+in+the+primary+structure+of+leucine-rich+alpha+2-glycoprotein+of+human+serum&amp;volume=82&amp;issue=7&amp;publication_year=1985&amp;pages=1906-10&amp;pmid=3856868&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B18">18. <span class="mixed-citation">Zhang A, Fang H, Chen J, He L, Chen Y. <span class="ref-title">Role of VEGF-A and LRG1 in abnormal angiogenesis associated with diabetic nephropathy</span>. <span class="ref-journal">Front Physiol</span>. 2020;<span class="ref-vol">11</span>:1064.
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7488177/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/32982792" ref="reftype=pubmed&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Front+Physiol&amp;title=Role+of+VEGF-A+and+LRG1+in+abnormal+angiogenesis+associated+with+diabetic+nephropathy&amp;volume=11&amp;publication_year=2020&amp;pages=1064&amp;pmid=32982792&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B19">19. <span class="mixed-citation">De Rossi G, Da Vitoria Lobo ME, Greenwood J, Moss SE. <span class="ref-title">LRG1 as a novel therapeutic target in eye disease</span>. <span class="ref-journal">Eye</span>. 2022;<span class="ref-vol">36</span>(<span class="ref-iss">2</span>):328&#x02013;40.
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC8807626/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/34987199" ref="reftype=pubmed&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Eye&amp;title=LRG1+as+a+novel+therapeutic+target+in+eye+disease&amp;volume=36&amp;issue=2&amp;publication_year=2022&amp;pages=328-40&amp;pmid=34987199&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B20">20. <span class="mixed-citation">Jemmerson R, Staskus K, Higgins L, Conklin K, Kelekar A. <span class="ref-title">Intracellular leucine-rich alpha-2-glycoprotein-1 competes with Apaf-1 for binding cytochrome c in protecting MCF-7 breast cancer cells from apoptosis</span>. <span class="ref-journal">Apoptosis</span>. 2021;<span class="ref-vol">26</span>(<span class="ref-iss">1&#x02013;2</span>):71&#x02013;82.
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7904597/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/33386492" ref="reftype=pubmed&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Apoptosis&amp;title=Intracellular+leucine-rich+alpha-2-glycoprotein-1+competes+with+Apaf-1+for+binding+cytochrome+c+in+protecting+MCF-7+breast+cancer+cells+from+apoptosis&amp;volume=26&amp;issue=1&#x02013;2&amp;publication_year=2021&amp;pages=71-82&amp;pmid=33386492&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B21">21. <span class="mixed-citation">Kubiczkova L, Sedlarikova L, Hajek R, Sevcikova S. <span class="ref-title">TGF-&#x003b2; - an excellent servant but a bad master</span>. <span class="ref-journal">J Transl Med</span>. 2012;<span class="ref-vol">10</span>:183.
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3494542/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/22943793" ref="reftype=pubmed&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Transl+Med&amp;title=TGF-&#x003b2;+-+an+excellent+servant+but+a+bad+master&amp;volume=10&amp;publication_year=2012&amp;pages=183&amp;pmid=22943793&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B22">22. <span class="mixed-citation">Camilli C, Hoeh AE, De Rossi G, Moss SE, Greenwood J. <span class="ref-title">LRG1: an emerging player in disease pathogenesis</span>. <span class="ref-journal">J Biomed Sci</span>. 2022;<span class="ref-vol">29</span>(<span class="ref-iss">1</span>):6.
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC8781713/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/35062948" ref="reftype=pubmed&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biomed+Sci&amp;title=LRG1:+an+emerging+player+in+disease+pathogenesis&amp;volume=29&amp;issue=1&amp;publication_year=2022&amp;pages=6&amp;pmid=35062948&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B23">23. <span class="mixed-citation">Lynch J, Fay J, Meehan M, Bryan K, Watters KM, Murphy DM, et al.. <span class="ref-title">MiRNA-335 suppresses neuroblastoma cell invasiveness by direct targeting of multiple genes from the non-canonical TGF-&#x003b2; signalling pathway</span>. <span class="ref-journal">Carcinogenesis</span>. 2012;<span class="ref-vol">33</span>(<span class="ref-iss">5</span>):976&#x02013;85.
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3334516/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/22382496" ref="reftype=pubmed&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Carcinogenesis&amp;title=MiRNA-335+suppresses+neuroblastoma+cell+invasiveness+by+direct+targeting+of+multiple+genes+from+the+non-canonical+TGF-&#x003b2;+signalling+pathway&amp;volume=33&amp;issue=5&amp;publication_year=2012&amp;pages=976-85&amp;pmid=22382496&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B24">24. <span class="mixed-citation">Su Q, Lv XW, Sun YH, Ye ZL, Kong BH, Qin ZB. <span class="ref-title">MicroRNA-494 inhibits the LRG1 expression to induce proliferation and migration of VECs in rats following myocardial infarction</span>. <span class="ref-journal">Mol Ther Nucleic Acids</span>. 2019;<span class="ref-vol">18</span>:110&#x02013;22.
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6796686/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/31541797" ref="reftype=pubmed&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Ther+Nucleic+Acids&amp;title=MicroRNA-494+inhibits+the+LRG1+expression+to+induce+proliferation+and+migration+of+VECs+in+rats+following+myocardial+infarction&amp;volume=18&amp;publication_year=2019&amp;pages=110-22&amp;pmid=31541797&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span><link class="retraction-forward" pmcaccid="PMC10196814" /> <a class="red" href="/pmc/articles/PMC10196814/">Retracted</a></span></div><div class="ref-cit-blk half_rhythm" id="B25">25. <span class="mixed-citation">Weivoda S, Andersen JD, Skogen A, Schlievert PM, Fontana D, Schacker T, et al.. <span class="ref-title">ELISA for human serum leucine-rich alpha-2-glycoprotein-1 employing cytochrome c as the capturing ligand</span>. <span class="ref-journal">J Immunol Methods</span>. 2008;<span class="ref-vol">336</span>(<span class="ref-iss">1</span>):22&#x02013;9.
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7094546/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/18436231" ref="reftype=pubmed&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Immunol+Methods&amp;title=ELISA+for+human+serum+leucine-rich+alpha-2-glycoprotein-1+employing+cytochrome+c+as+the+capturing+ligand&amp;volume=336&amp;issue=1&amp;publication_year=2008&amp;pages=22-9&amp;pmid=18436231&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B26">26. <span class="mixed-citation">Druhan LJ, Lance A, Li S, Price AE, Emerson JT, Baxter SA, et al.. <span class="ref-title">Leucine rich alpha-2 glycoprotein: a novel neutrophil granule protein and modulator of myelopoiesis</span>. <span class="ref-journal">PLoS One</span>. 2017;<span class="ref-vol">12</span>:e170261. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5233425/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/28081565" ref="reftype=pubmed&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=PLoS+One&amp;title=Leucine+rich+alpha-2+glycoprotein:+a+novel+neutrophil+granule+protein+and+modulator+of+myelopoiesis&amp;volume=12&amp;publication_year=2017&amp;pages=e170261&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B27">27. <span class="mixed-citation">Hong Q, Zhang L, Fu J, Verghese DA, Chauhan K, Nadkarni GN, et al.. <span class="ref-title">LRG1 promotes diabetic kidney disease progression by enhancing TGF-<em>&#x003b2;</em>-induced angiogenesis</span>. <span class="ref-journal">J Am Soc Nephrol</span>. 2019;<span class="ref-vol">30</span>(<span class="ref-iss">4</span>):546&#x02013;62.
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6442349/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/30858225" ref="reftype=pubmed&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Am+Soc+Nephrol&amp;title=LRG1+promotes+diabetic+kidney+disease+progression+by+enhancing+TGF-&#x003b2;-induced+angiogenesis&amp;volume=30&amp;issue=4&amp;publication_year=2019&amp;pages=546-62&amp;pmid=30858225&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B28">28. <span class="mixed-citation">Shahin D H H, Sultana R, Farooq J, Taj T, Khaiser UF, Alanazi N, et al.. <span class="ref-title">Insights into the uses of traditional plants for diabetes nephropathy: a review</span>. <span class="ref-journal">Curr Issues Mol Biol</span>. 2022;<span class="ref-vol">44</span>(<span class="ref-iss">7</span>):2887&#x02013;902.
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC9316237/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/35877423" ref="reftype=pubmed&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Curr+Issues+Mol+Biol&amp;title=Insights+into+the+uses+of+traditional+plants+for+diabetes+nephropathy:+a+review&amp;volume=44&amp;issue=7&amp;publication_year=2022&amp;pages=2887-902&amp;pmid=35877423&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B29">29. <span class="mixed-citation">Zhang XX, Kong J, Yun K. <span class="ref-title">Prevalence of diabetic nephropathy among patients with type 2 diabetes mellitus in China: a meta-analysis of observational studies</span>. <span class="ref-journal">J Diabetes Res</span>. 2020;<span class="ref-vol">2020</span>:1&#x02013;11. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7023800/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/32090116" ref="reftype=pubmed&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Diabetes+Res&amp;title=Prevalence+of+diabetic+nephropathy+among+patients+with+type+2+diabetes+mellitus+in+China:+a+meta-analysis+of+observational+studies&amp;volume=2020&amp;publication_year=2020&amp;pages=1-11&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B30">30. <span class="mixed-citation">Singh H, Yu Y, Suh MJ, Torralba MG, Stenzel RD, Tovchigrechko A, et al.. <span class="ref-title">Type 1 diabetes: urinary proteomics and protein network analysis support perturbation of lysosomal function</span>. <span class="ref-journal">Theranostics</span>. 2017;<span class="ref-vol">7</span>(<span class="ref-iss">10</span>):2704&#x02013;17.
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5558563/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/28819457" ref="reftype=pubmed&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Theranostics&amp;title=Type+1+diabetes:+urinary+proteomics+and+protein+network+analysis+support+perturbation+of+lysosomal+function&amp;volume=7&amp;issue=10&amp;publication_year=2017&amp;pages=2704-17&amp;pmid=28819457&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B31">31. <span class="mixed-citation">Liu JJ, Liu S, Wang J, Pek S, Lee J, Gurung RL, et al.. <span class="ref-title">Urine leucine-rich &#x003b1;-2 glycoprotein 1 (LRG1) predicts the risk of progression to end-stage kidney disease in patients with type 2 diabetes</span>. <span class="ref-journal">Diabetes Care</span>. 2023;<span class="ref-vol">46</span>:408&#x02013;15.
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC9887617/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/36516193" ref="reftype=pubmed&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes+Care&amp;title=Urine+leucine-rich+&#x003b1;-2+glycoprotein+1+(LRG1)+predicts+the+risk+of+progression+to+end-stage+kidney+disease+in+patients+with+type+2+diabetes&amp;volume=46&amp;publication_year=2023&amp;pages=408-15&amp;pmid=36516193&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B32">32. <span class="mixed-citation">Gurung RL, Dorajoo R, Liu JJ, Liu JJ, Pek SLT, Wang J, et al.. <span class="ref-title">Association of genetic variants for plasma LRG1 with rapid decline in kidney function in patients with type 2 diabetes</span>. <span class="ref-journal">J Clin Endocrinol Metab</span>. 2021;<span class="ref-vol">106</span>(<span class="ref-iss">8</span>):2384&#x02013;94.
 [<a href="https://pubmed.ncbi.nlm.nih.gov/33889958" ref="reftype=pubmed&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Endocrinol+Metab&amp;title=Association+of+genetic+variants+for+plasma+LRG1+with+rapid+decline+in+kidney+function+in+patients+with+type+2+diabetes&amp;volume=106&amp;issue=8&amp;publication_year=2021&amp;pages=2384-94&amp;pmid=33889958&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B33">33. <span class="mixed-citation">Fu J, Wei C, Zhang W, Schlondorff D, Wu J, Cai M, et al.. <span class="ref-title">Gene expression profiles of glomerular endothelial cells support their role in the glomerulopathy of diabetic mice</span>. <span class="ref-journal">Kidney Int</span>. 2018;<span class="ref-vol">94</span>(<span class="ref-iss">2</span>):326&#x02013;45.
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6054896/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29861058" ref="reftype=pubmed&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Kidney+Int&amp;title=Gene+expression+profiles+of+glomerular+endothelial+cells+support+their+role+in+the+glomerulopathy+of+diabetic+mice&amp;volume=94&amp;issue=2&amp;publication_year=2018&amp;pages=326-45&amp;pmid=29861058&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B34">34. <span class="mixed-citation">Kang DH, Kim YG, Andoh TF, Gordon KL, Suga S, Mazzali M, et al.. <span class="ref-title">Post-cyclosporine-mediated hypertension and nephropathy: amelioration by vascular endothelial growth factor</span>. <span class="ref-journal">Am J Physiol Ren Physiol</span>. 2001;<span class="ref-vol">280</span>(<span class="ref-iss">4</span>):F727&#x02013;36. [<a href="https://pubmed.ncbi.nlm.nih.gov/11249864" ref="reftype=pubmed&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Physiol+Ren+Physiol&amp;title=Post-cyclosporine-mediated+hypertension+and+nephropathy:+amelioration+by+vascular+endothelial+growth+factor&amp;volume=280&amp;issue=4&amp;publication_year=2001&amp;pages=F727-36&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B35">35. <span class="mixed-citation">Haku S, Wakui H, Azushima K, Haruhara K, Kinguchi S, Ohki K, et al.. <span class="ref-title">Early enhanced leucine-rich <em>&#x003b1;</em>-2-glycoprotein-1 expression in glomerular endothelial cells of type 2 diabetic nephropathy model mice</span>. <span class="ref-journal">BioMed Res Int</span>. 2018;<span class="ref-vol">2018</span>:2817045.
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6236974/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/30515388" ref="reftype=pubmed&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=BioMed+Res+Int&amp;title=Early+enhanced+leucine-rich+&#x003b1;-2-glycoprotein-1+expression+in+glomerular+endothelial+cells+of+type+2+diabetic+nephropathy+model+mice&amp;volume=2018&amp;publication_year=2018&amp;pages=2817045&amp;pmid=30515388&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B36">36. <span class="mixed-citation">Jin J, Sun H, Liu D, Wang H, Liu Q, Chen H, et al.. <span class="ref-title">LRG1 promotes apoptosis and autophagy through the tgf&#x003b2;-smad1/5 signaling pathway to exacerbate ischemia/reperfusion injury</span>. <span class="ref-journal">Neuroscience</span>. 2019;<span class="ref-vol">413</span>:123&#x02013;34.
 [<a href="https://pubmed.ncbi.nlm.nih.gov/31220542" ref="reftype=pubmed&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Neuroscience&amp;title=LRG1+promotes+apoptosis+and+autophagy+through+the+tgf&#x003b2;-smad1/5+signaling+pathway+to+exacerbate+ischemia/reperfusion+injury&amp;volume=413&amp;publication_year=2019&amp;pages=123-34&amp;pmid=31220542&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B37">37. <span class="mixed-citation">Mohammad H, Galal Gouda S, Eladl MA, Elkazaz AY, Elbayoumi KS, Farag NE, et al.. <span class="ref-title">Metformin suppresses LRG1 and TGF&#x003b2;1/ALK1-induced angiogenesis and protects against ultrastructural changes in rat diabetic nephropathy</span>. <span class="ref-journal">Biomed Pharmacother</span>. 2023;<span class="ref-vol">158</span>:114128.
 [<a href="https://pubmed.ncbi.nlm.nih.gov/36525822" ref="reftype=pubmed&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biomed+Pharmacother&amp;title=Metformin+suppresses+LRG1+and+TGF&#x003b2;1/ALK1-induced+angiogenesis+and+protects+against+ultrastructural+changes+in+rat+diabetic+nephropathy&amp;volume=158&amp;publication_year=2023&amp;pages=114128&amp;pmid=36525822&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B38">38. <span class="mixed-citation">Jiang WJ, Xu CT, Du CL, Dong JH, Xu SB, Hu BF, et al.. <span class="ref-title">Tubular epithelial cell-to-macrophage communication forms a negative feedback loop via extracellular vesicle transfer to promote renal inflammation and apoptosis in diabetic nephropathy</span>. <span class="ref-journal">Theranostics</span>. 2022;<span class="ref-vol">12</span>(<span class="ref-iss">1</span>):324&#x02013;39.
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC8690920/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/34987648" ref="reftype=pubmed&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Theranostics&amp;title=Tubular+epithelial+cell-to-macrophage+communication+forms+a+negative+feedback+loop+via+extracellular+vesicle+transfer+to+promote+renal+inflammation+and+apoptosis+in+diabetic+nephropathy&amp;volume=12&amp;issue=1&amp;publication_year=2022&amp;pages=324-39&amp;pmid=34987648&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B39">39. <span class="mixed-citation">Matsuura R, Doi K, Rabb H. <span class="ref-title">Acute kidney injury and distant organ dysfunction-network system analysis</span>. <span class="ref-journal">Kidney Int</span>. 2023;<span class="ref-vol">103</span>(<span class="ref-iss">6</span>):1041&#x02013;55.
 [<a href="https://pubmed.ncbi.nlm.nih.gov/37030663" ref="reftype=pubmed&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Kidney+Int&amp;title=Acute+kidney+injury+and+distant+organ+dysfunction-network+system+analysis&amp;volume=103&amp;issue=6&amp;publication_year=2023&amp;pages=1041-55&amp;pmid=37030663&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B40">40. <span class="mixed-citation">Hashida T, Nakada TA, Satoh M, Tomita K, Kawaguchi R, Nomura F, et al.. <span class="ref-title">Proteome analysis of hemofilter adsorbates to identify novel substances of sepsis: a pilot study</span>. <span class="ref-journal">J Artif Organs</span>. 2017;<span class="ref-vol">20</span>(<span class="ref-iss">2</span>):132&#x02013;7.
 [<a href="https://pubmed.ncbi.nlm.nih.gov/27858178" ref="reftype=pubmed&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Artif+Organs&amp;title=Proteome+analysis+of+hemofilter+adsorbates+to+identify+novel+substances+of+sepsis:+a+pilot+study&amp;volume=20&amp;issue=2&amp;publication_year=2017&amp;pages=132-7&amp;pmid=27858178&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B41">41. <span class="mixed-citation">Zarbock A, Nadim MK, Pickkers P, Gomez H, Bell S, Joannidis M, et al.. <span class="ref-title">Sepsis-associated acute kidney injury: consensus report of the 28th Acute Disease Quality Initiative workgroup</span>. <span class="ref-journal">Nat Rev Nephrol</span>. 2023;<span class="ref-vol">19</span>(<span class="ref-iss">6</span>):401&#x02013;17.
 [<a href="https://pubmed.ncbi.nlm.nih.gov/36823168" ref="reftype=pubmed&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Rev+Nephrol&amp;title=Sepsis-associated+acute+kidney+injury:+consensus+report+of+the+28th+Acute+Disease+Quality+Initiative+workgroup&amp;volume=19&amp;issue=6&amp;publication_year=2023&amp;pages=401-17&amp;pmid=36823168&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B42">42. <span class="mixed-citation">Davoudi M, Jadidi Y, Moayedi K, Farrokhi V, Afrisham R. <span class="ref-title">Ameliorative impacts of polymeric and metallic nanoparticles on cisplatin-induced nephrotoxicity: a 2011-2022 review</span>. <span class="ref-journal">J Nanobiotechnology</span>. 2022;<span class="ref-vol">20</span>(<span class="ref-iss">1</span>):504.
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC9714065/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/36457031" ref="reftype=pubmed&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Nanobiotechnology&amp;title=Ameliorative+impacts+of+polymeric+and+metallic+nanoparticles+on+cisplatin-induced+nephrotoxicity:+a+2011-2022+review&amp;volume=20&amp;issue=1&amp;publication_year=2022&amp;pages=504&amp;pmid=36457031&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B43">43. <span class="mixed-citation">Jiang W, Ma T, Zhang C, Tang X, Xu Q, Meng X, et al.. <span class="ref-title">Identification of urinary candidate biomarkers of cisplatin-induced nephrotoxicity in patients with carcinoma</span>. <span class="ref-journal">J Proteomics</span>. 2020;<span class="ref-vol">210</span>:103533.
 [<a href="https://pubmed.ncbi.nlm.nih.gov/31629959" ref="reftype=pubmed&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Proteomics&amp;title=Identification+of+urinary+candidate+biomarkers+of+cisplatin-induced+nephrotoxicity+in+patients+with+carcinoma&amp;volume=210&amp;publication_year=2020&amp;pages=103533&amp;pmid=31629959&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B44">44. <span class="mixed-citation">Anfaiha-Sanchez M, Rodrigo Calabia E, Ortiz A, Martin-Lorenzo M, Alvarez-Llamas G. <span class="ref-title">Donor liquid biopsy and outcomes in kidney transplantation</span>. <span class="ref-journal">Clin Kidney J</span>. 2023;<span class="ref-vol">16</span>(<span class="ref-iss">3</span>):447&#x02013;55.
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC9972840/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/36865017" ref="reftype=pubmed&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Kidney+J&amp;title=Donor+liquid+biopsy+and+outcomes+in+kidney+transplantation&amp;volume=16&amp;issue=3&amp;publication_year=2023&amp;pages=447-55&amp;pmid=36865017&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B45">45. <span class="mixed-citation">Popova A, Vasilvolfa A, Racenis K, Erts R, Slisere B, Saulite AJ, et al.. <span class="ref-title">Leucine-rich alpha-2-glycoprotein (LRG-1) as a potential kidney injury marker in kidney transplant recipients</span>. <span class="ref-journal">Ann Transplant</span>. 2022;<span class="ref-vol">27</span>:e936751.
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC9463878/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/36065144" ref="reftype=pubmed&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Ann+Transplant&amp;title=Leucine-rich+alpha-2-glycoprotein+(LRG-1)+as+a+potential+kidney+injury+marker+in+kidney+transplant+recipients&amp;volume=27&amp;publication_year=2022&amp;pages=e936751&amp;pmid=36065144&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B46">46. <span class="mixed-citation">Lee H, Fujimoto M, Ohkawara T, Honda H, Serada S, Terada Y, et al.. <span class="ref-title">Leucine rich &#x003b1;-2 glycoprotein is a potential urinary biomarker for renal tubular injury</span>. <span class="ref-journal">Biochem Biophys Res Commun</span>. 2018;<span class="ref-vol">498</span>(<span class="ref-iss">4</span>):1045&#x02013;51.
 [<a href="https://pubmed.ncbi.nlm.nih.gov/29550485" ref="reftype=pubmed&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biochem+Biophys+Res+Commun&amp;title=Leucine+rich+&#x003b1;-2+glycoprotein+is+a+potential+urinary+biomarker+for+renal+tubular+injury&amp;volume=498&amp;issue=4&amp;publication_year=2018&amp;pages=1045-51&amp;pmid=29550485&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B47">47. <span class="mixed-citation">Shirai R, Hirano F, Ohkura N, Ikeda K, Inoue S. <span class="ref-title">Up-regulation of the expression of leucine-rich &#x003b1;2-glycoprotein in hepatocytes by the mediators of acute-phase response</span>. <span class="ref-journal">Biochem Biophys Res Commun</span>. 2009;<span class="ref-vol">382</span>(<span class="ref-iss">4</span>):776&#x02013;9.
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7092932/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/19324010" ref="reftype=pubmed&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biochem+Biophys+Res+Commun&amp;title=Up-regulation+of+the+expression+of+leucine-rich+&#x003b1;2-glycoprotein+in+hepatocytes+by+the+mediators+of+acute-phase+response&amp;volume=382&amp;issue=4&amp;publication_year=2009&amp;pages=776-9&amp;pmid=19324010&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B48">48. <span class="mixed-citation">Honda H, Fujimoto M, Miyamoto S, Ishikawa N, Serada S, Hattori N, et al.. <span class="ref-title">Sputum leucine-rich alpha-2 glycoprotein as a marker of airway inflammation in asthma</span>. <span class="ref-journal">PLoS One</span>. 2016;<span class="ref-vol">11</span>(<span class="ref-iss">9</span>):e0162672.
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5017625/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/27611322" ref="reftype=pubmed&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=PLoS+One&amp;title=Sputum+leucine-rich+alpha-2+glycoprotein+as+a+marker+of+airway+inflammation+in+asthma&amp;volume=11&amp;issue=9&amp;publication_year=2016&amp;pages=e0162672&amp;pmid=27611322&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B49">49. <span class="mixed-citation">Muk T, Jiang PP, Stensballe A, Skovgaard K, Sangild PT, Nguyen DN. <span class="ref-title">Prenatal endotoxin exposure induces fetal and neonatal renal inflammation via innate and Th1 immune activation in preterm pigs</span>. <span class="ref-journal">Front Immunol</span>. 2020;<span class="ref-vol">11</span>:565484.
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7643587/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/33193334" ref="reftype=pubmed&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Front+Immunol&amp;title=Prenatal+endotoxin+exposure+induces+fetal+and+neonatal+renal+inflammation+via+innate+and+Th1+immune+activation+in+preterm+pigs&amp;volume=11&amp;publication_year=2020&amp;pages=565484&amp;pmid=33193334&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B50">50. <span class="mixed-citation">Du Y, Cheng T, Liu C, Zhu T, Guo C, Li S, et al.. <span class="ref-title">IgA nephropathy: current understanding and perspectives on pathogenesis and targeted treatment</span>. <span class="ref-journal">Diagnostics</span>. 2023;<span class="ref-vol">13</span>(<span class="ref-iss">2</span>):303.
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC9857562/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/36673113" ref="reftype=pubmed&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Diagnostics&amp;title=IgA+nephropathy:+current+understanding+and+perspectives+on+pathogenesis+and+targeted+treatment&amp;volume=13&amp;issue=2&amp;publication_year=2023&amp;pages=303&amp;pmid=36673113&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B51">51. <span class="mixed-citation">Khositseth S, Kanitsap N, Warnnissorn N, Thongboonkerd V. <span class="ref-title">IgA nephropathy associated with Hodgkin&#x02019;s disease in children: a case report, literature review and urinary proteome analysis</span>. <span class="ref-journal">Pediatr Nephrol</span>. 2007;<span class="ref-vol">22</span>(<span class="ref-iss">4</span>):541&#x02013;6.
 [<a href="https://pubmed.ncbi.nlm.nih.gov/17143626" ref="reftype=pubmed&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Pediatr+Nephrol&amp;title=IgA+nephropathy+associated+with+Hodgkin&#x02019;s+disease+in+children:+a+case+report,+literature+review+and+urinary+proteome+analysis&amp;volume=22&amp;issue=4&amp;publication_year=2007&amp;pages=541-6&amp;pmid=17143626&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B52">52. <span class="mixed-citation">Liu TT, Luo R, Yang Y, Cheng YC, Chang D, Dai W, et al.. <span class="ref-title">LRG1 mitigates renal interstitial fibrosis through alleviating capillary rarefaction and inhibiting inflammatory and pro-fibrotic cytokines</span>. <span class="ref-journal">Am J Nephrol</span>. 2021;<span class="ref-vol">52</span>(<span class="ref-iss">3</span>):228&#x02013;38.
 [<a href="https://pubmed.ncbi.nlm.nih.gov/33823527" ref="reftype=pubmed&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Nephrol&amp;title=LRG1+mitigates+renal+interstitial+fibrosis+through+alleviating+capillary+rarefaction+and+inhibiting+inflammatory+and+pro-fibrotic+cytokines&amp;volume=52&amp;issue=3&amp;publication_year=2021&amp;pages=228-38&amp;pmid=33823527&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B53">53. <span class="mixed-citation">Wilson SE. <span class="ref-title">TGF beta -1, -2 and -3 in the modulation of fibrosis in the cornea and other organs</span>. <span class="ref-journal">Exp Eye Res</span>. 2021;<span class="ref-vol">207</span>:108594.
 [<a href="https://pubmed.ncbi.nlm.nih.gov/33894227" ref="reftype=pubmed&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Exp+Eye+Res&amp;title=TGF+beta+-1,+-2+and+-3+in+the+modulation+of+fibrosis+in+the+cornea+and+other+organs&amp;volume=207&amp;publication_year=2021&amp;pages=108594&amp;pmid=33894227&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B54">54. <span class="mixed-citation">Kalantari S, Rutishauser D, Samavat S, Nafar M, Mahmudieh L, Rezaei-Tavirani M, et al.. <span class="ref-title">Urinary prognostic biomarkers and classification of IgA nephropathy by high resolution mass spectrometry coupled with liquid chromatography</span>. <span class="ref-journal">PLoS One</span>. 2013;<span class="ref-vol">8</span>(<span class="ref-iss">12</span>):e80830.
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3855054/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/24339887" ref="reftype=pubmed&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=PLoS+One&amp;title=Urinary+prognostic+biomarkers+and+classification+of+IgA+nephropathy+by+high+resolution+mass+spectrometry+coupled+with+liquid+chromatography&amp;volume=8&amp;issue=12&amp;publication_year=2013&amp;pages=e80830&amp;pmid=24339887&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B55">55. <span class="mixed-citation">Ulasi II, Awobusuyi O, Nayak S, Ramachandran R, Musso CG, Depine SA, et al.. <span class="ref-title">Chronic kidney disease burden in low-resource settings: regional perspectives</span>. <span class="ref-journal">Semin Nephrol</span>. 2022;<span class="ref-vol">42</span>(<span class="ref-iss">5</span>):151336.
 [<a href="https://pubmed.ncbi.nlm.nih.gov/37058859" ref="reftype=pubmed&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Semin+Nephrol&amp;title=Chronic+kidney+disease+burden+in+low-resource+settings:+regional+perspectives&amp;volume=42&amp;issue=5&amp;publication_year=2022&amp;pages=151336&amp;pmid=37058859&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B56">56. <span class="mixed-citation">Low S, Pek S, Moh A, Khin C, Lim CL, Ang SF, et al.. <span class="ref-title">Low muscle mass is associated with progression of chronic kidney disease and albuminuria: an 8-year longitudinal study in Asians with Type 2 Diabetes</span>. <span class="ref-journal">Diabetes Res Clin Pract</span>. 2021;<span class="ref-vol">174</span>:108777.
 [<a href="https://pubmed.ncbi.nlm.nih.gov/33745995" ref="reftype=pubmed&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes+Res+Clin+Pract&amp;title=Low+muscle+mass+is+associated+with+progression+of+chronic+kidney+disease+and+albuminuria:+an+8-year+longitudinal+study+in+Asians+with+Type+2+Diabetes&amp;volume=174&amp;publication_year=2021&amp;pages=108777&amp;pmid=33745995&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B57">57. <span class="mixed-citation">Yamagishi S, Matsui T, Nakamura K, Ueda S, Noda Y, Imaizumi T. <span class="ref-title">Pigment epithelium-derived factor (PEDF): its potential therapeutic implication in diabetic vascular complications</span>. <span class="ref-journal">Curr Drug Targets</span>. 2008;<span class="ref-vol">9</span>(<span class="ref-iss">11</span>):1025&#x02013;9.
 [<a href="https://pubmed.ncbi.nlm.nih.gov/18991613" ref="reftype=pubmed&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Curr+Drug+Targets&amp;title=Pigment+epithelium-derived+factor+(PEDF):+its+potential+therapeutic+implication+in+diabetic+vascular+complications&amp;volume=9&amp;issue=11&amp;publication_year=2008&amp;pages=1025-9&amp;pmid=18991613&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B58">58. <span class="mixed-citation">Hui E, Yeung CY, Lee PC, Woo YC, Fong CH, Chow WS, et al.. <span class="ref-title">Elevated circulating pigment epithelium-derived factor predicts the progression of diabetic nephropathy in patients with type 2 diabetes</span>. <span class="ref-journal">J Clin Endocrinol Metab</span>. 2014;<span class="ref-vol">99</span>(<span class="ref-iss">11</span>):E2169&#x02013;77.
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4223434/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/25166721" ref="reftype=pubmed&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Endocrinol+Metab&amp;title=Elevated+circulating+pigment+epithelium-derived+factor+predicts+the+progression+of+diabetic+nephropathy+in+patients+with+type+2+diabetes&amp;volume=99&amp;issue=11&amp;publication_year=2014&amp;pages=E2169-77&amp;pmid=25166721&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B59">59. <span class="mixed-citation">Low S, Pek S, Moh A, Ang K, Khoo J, Shao YM, et al.. <span class="ref-title">Triglyceride-glucose index is prospectively associated with chronic kidney disease progression in Type 2 diabetes: mediation by pigment epithelium-derived factor</span>. <span class="ref-journal">Diab Vasc Dis Res</span>. 2022;<span class="ref-vol">19</span>(<span class="ref-iss">4</span>):14791641221113784.
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC9364218/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/35938490" ref="reftype=pubmed&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Diab+Vasc+Dis+Res&amp;title=Triglyceride-glucose+index+is+prospectively+associated+with+chronic+kidney+disease+progression+in+Type+2+diabetes:+mediation+by+pigment+epithelium-derived+factor&amp;volume=19&amp;issue=4&amp;publication_year=2022&amp;pages=14791641221113784&amp;pmid=35938490&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B60">60. <span class="mixed-citation">Wang JJ, Zhang SX, Lu K, Chen Y, Mott R, Sato S, et al.. <span class="ref-title">Decreased expression of pigment epithelium-derived factor is involved in the pathogenesis of diabetic nephropathy</span>. <span class="ref-journal">Diabetes</span>. 2005;<span class="ref-vol">54</span>(<span class="ref-iss">1</span>):243&#x02013;50.
 [<a href="https://pubmed.ncbi.nlm.nih.gov/15616035" ref="reftype=pubmed&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes&amp;title=Decreased+expression+of+pigment+epithelium-derived+factor+is+involved+in+the+pathogenesis+of+diabetic+nephropathy&amp;volume=54&amp;issue=1&amp;publication_year=2005&amp;pages=243-50&amp;pmid=15616035&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B61">61. <span class="mixed-citation">Hong Q, Wang S, Liu S, Chen X, Cai G. <span class="ref-title">LRG1 may accelerate the progression of ccRCC via the TGF-<em>&#x003b2;</em> pathway</span>. <span class="ref-journal">BioMed Res Int</span>. 2020;<span class="ref-vol">2020</span>:1285068.
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7149433/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/32337221" ref="reftype=pubmed&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=BioMed+Res+Int&amp;title=LRG1+may+accelerate+the+progression+of+ccRCC+via+the+TGF-&#x003b2;+pathway&amp;volume=2020&amp;publication_year=2020&amp;pages=1285068&amp;pmid=32337221&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B62">62. <span class="mixed-citation">Yang Y, Luo R, Cheng Y, Liu T, Dai W, Li Y, et al.. <span class="ref-title">Leucine-rich &#x003b1;2-glycoprotein-1 upregulation in plasma and kidney of patients with lupus nephritis</span>. <span class="ref-journal">BMC Nephrol</span>. 2020;<span class="ref-vol">21</span>(<span class="ref-iss">1</span>):122.
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7137487/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/32252660" ref="reftype=pubmed&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=BMC+Nephrol&amp;title=Leucine-rich+&#x003b1;2-glycoprotein-1+upregulation+in+plasma+and+kidney+of+patients+with+lupus+nephritis&amp;volume=21&amp;issue=1&amp;publication_year=2020&amp;pages=122&amp;pmid=32252660&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B63">63. <span class="mixed-citation">Yang FJ, Hsieh CY, Shu KH, Chen IY, Pan SY, Chuang YF, et al.. <span class="ref-title">Plasma leucine-rich &#x003b1;-2-glycoprotein 1 predicts cardiovascular disease risk in end-stage renal disease</span>. <span class="ref-journal">Sci Rep</span>. 2020;<span class="ref-vol">10</span>:5988.
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7136266/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/32249825" ref="reftype=pubmed&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Sci+Rep&amp;title=Plasma+leucine-rich+&#x003b1;-2-glycoprotein+1+predicts+cardiovascular+disease+risk+in+end-stage+renal+disease&amp;volume=10&amp;publication_year=2020&amp;pages=5988&amp;pmid=32249825&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B64">64. <span class="mixed-citation">Gonzalez MA, Barrera-Chacon R, Pena FJ, Fernandez-Cotrina J, Robles NR, Perez-Merino EM, et al.. <span class="ref-title">Urinary proteome of dogs with renal disease secondary to leishmaniosis</span>. <span class="ref-journal">Res Vet Sci</span>. 2022;<span class="ref-vol">149</span>:108&#x02013;18.
 [<a href="https://pubmed.ncbi.nlm.nih.gov/35777279" ref="reftype=pubmed&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Res+Vet+Sci&amp;title=Urinary+proteome+of+dogs+with+renal+disease+secondary+to+leishmaniosis&amp;volume=149&amp;publication_year=2022&amp;pages=108-18&amp;pmid=35777279&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B65">65. <span class="mixed-citation">Hong Q, Cai H, Zhang L, Li Z, Zhong F, Ni Z, et al.. <span class="ref-title">Modulation of transforming growth factor-&#x003b2;-induced kidney fibrosis by leucine-rich &#x0237a;-2 glycoprotein-1</span>. <span class="ref-journal">Kidney Int</span>. 2022;<span class="ref-vol">101</span>(<span class="ref-iss">2</span>):299&#x02013;314.
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC8792236/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/34774561" ref="reftype=pubmed&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Kidney+Int&amp;title=Modulation+of+transforming+growth+factor-&#x003b2;-induced+kidney+fibrosis+by+leucine-rich+&#x0237a;-2+glycoprotein-1&amp;volume=101&amp;issue=2&amp;publication_year=2022&amp;pages=299-314&amp;pmid=34774561&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B66">66. <span class="mixed-citation">Jiang W, Xu C, Xu S, Su W, Du C, Dong J, et al.. <span class="ref-title">Macrophage-derived, LRG1-enriched extracellular vesicles exacerbate aristolochic acid nephropathy in a TGF&#x003b2;R1-dependent manner</span>. <span class="ref-journal">Cell Biol Toxicol</span>. 2022;<span class="ref-vol">38</span>(<span class="ref-iss">4</span>):629&#x02013;48.
 [<a href="https://pubmed.ncbi.nlm.nih.gov/34677723" ref="reftype=pubmed&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell+Biol+Toxicol&amp;title=Macrophage-derived,+LRG1-enriched+extracellular+vesicles+exacerbate+aristolochic+acid+nephropathy+in+a+TGF&#x003b2;R1-dependent+manner&amp;volume=38&amp;issue=4&amp;publication_year=2022&amp;pages=629-48&amp;pmid=34677723&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11126829&amp;issue-id=463320&amp;journal-id=3013&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div></div></div></div><!--post-content--><div class="courtesy-note whole_rhythm small"><hr /><div class="half_rhythm">Articles from <span class="acknowledgment-journal-title">Kidney Diseases</span> are provided here courtesy of <strong>Karger Publishers</strong></div><hr /></div><div id="body-link-poppers"><span></span></div></div>
            
        </section>
    </article>
    <aside class="usa-width-one-fourth usa-layout-docs-sidenav pmc-sidebar">
         
  

<div class="scroller">

    
        <section>
                <h6>Other Formats</h6>
                <ul class="pmc-sidebar__formats">
                  <li class="pdf-link other_item"><a href="/pmc/articles/PMC11126829/pdf/kdd-2024-0010-0003-538443.pdf" class="int-view">PDF (415K)</a></li>
                </ul>
        </section>
    
    <section>
        <h6>Actions</h6>
        <ul class="pmc-sidebar__actions">
            <li>
                <button role="button" class="citation-button citation-dialog-trigger ctxp"
                        aria-label="Open dialog with citation text in different styles" data-ga-category="save_share" data-ga-action="cite" data-ga-label="open"
                        data-all-citations-url="/pmc/resources/citations/11126829/"
                        data-citation-style="nlm"
                        data-download-format-link="/pmc/resources/citations/11126829/export/"
                >
                    <span class="button-label">Cite</span>
                </button>
            </li>
            <li>
                
                    

<link type="text/css" href="ncbi-overlay-block/src/overlay-block.css">
<div class="collections-button-container" data-article-id="11126829" data-article-db="pmc">
  <button class="collections-button collections-dialog-trigger"
          aria-label="Save article in MyNCBI collections."
          data-ga-category="collections_button"
          data-ga-action="click"
          data-ga-label="collections_button"
          data-collections-open-dialog-enabled="false"
          data-collections-open-dialog-url="https://www.ncbi.nlm.nih.gov/account?back_url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC11126829%2F%23open-collections-dialog"
          data-in-collections="false">
      <span class="button-label">Collections</span>
  </button>
  <div class="overlay" role="dialog">
  <div id="collections-action-dialog"
       class="dialog collections-dialog"
       aria-hidden="true">
    <div class="title">Add to Collections</div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/pmc/list-existing-collections/"
      data-add-to-existing-collection-url="/pmc/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/pmc/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

  <input type="hidden" name="csrfmiddlewaretoken" value="Eqvfl3qGZqC8LNdePX4i3AXVULvHOFYI0wfTKoLZA5XCa3fOm2HBz8SB2ml8xSTL">

  

  <div class="choice-group" role="radiogroup">
    <ul class="radio-group-items">
      <li>
        <input type="radio"
               id="collections-action-dialog-new-aside "
               class="collections-new"
               name="collections"
               value="new"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_new">
        <label for="collections-action-dialog-new-aside ">Create a new collection</label>
      </li>
      <li>
        <input type="radio"
               id="collections-action-dialog-existing-aside "
               class="collections-existing"
               name="collections"
               value="existing"
               checked="true"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_existing">
        <label for="collections-action-dialog-existing-aside ">Add to an existing collection</label>
      </li>
    </ul>
  </div>

  <div class="controls-wrapper">
    <div class="action-panel-control-wrap new-collections-controls">
      <label for="collections-action-dialog-add-to-new" class="action-panel-label required-field-asterisk">
        Name your collection:
      </label>
      <input
        type="text"
        name="add-to-new-collection"
        id="collections-action-dialog-add-to-new"
        class="collections-action-add-to-new"
        pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
        maxlength=""
        data-ga-category="collections_button"
        data-ga-action="create_collection"
        data-ga-label="non_favorties_collection">
      <div class="collections-new-name-too-long usa-input-error-message selection-validation-message">
        Name must be less than  characters
      </div>
    </div>
    <div class="action-panel-control-wrap existing-collections-controls">
      <label for="collections-action-dialog-add-to-existing" class="action-panel-label">
        Choose a collection:
      </label>
      <select id="collections-action-dialog-add-to-existing"
              class="action-panel-selector collections-action-add-to-existing"
              data-ga-category="collections_button"
              data-ga-action="select_collection"
              data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
      </select>
      <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
        Unable to load your collection due to an error<br>
        <a href="#">Please try again</a>
      </div>
    </div>
  </div>

  <div class="action-panel-actions">
    <button class="action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
      Add
    </button>
    <button class="action-panel-cancel"
            aria-label="Close 'Add to Collections' panel"
            ref="linksrc=close_collections_panel"
            aria-controls="collections-action-panel"
            aria-expanded="false"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="cancel">
      Cancel
    </button>
  </div>
</form>
    </div>
  </div>
</div>
</div>
                
            </li>

        </ul>
    </section>
    
        <section class="social-sharing">
            <h6>Share</h6>
            <ul class="pmc-sidebar__share">
                <li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC11126829%2F&amp;text=LRG1%20Contributes%20to%20the%20Pathogenesis%20of%20Multiple%20Kidney%20Diseases%3A%20A%20Comprehensive%20Review" alt="Share on Twitter"><i class="fa fa-twitter fa-stack-1x">&#160;</i></a></li> 
<li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC11126829%2F" alt="Share on Facebook"><i class="fa fa-facebook fa-stack-1x">&#160;</i></a></li>
                <li>
                    <div class="share-permalink">
                        <button class="trigger"  alt="Show article permalink" aria-expanded="false" aria-haspopup="true">
                            <i class="fa-stack fa-lg" >
                                <i class="fa fa-link fa-stack-1x">&nbsp;</i>
                            </i>
                        </button>
                        <div class="dropdown dropdown-container" hidden>
                              <div class="title">
                                Permalink
                              </div>
                              <div class="content">
                                  <input type="text" class="permalink-text" value="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11126829/" aria-label="Article permalink"><button class="permalink-copy-button usa-button-primary" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                                      <span class="button-title">Copy</span>
                                  </button>
                              </div>
                        </div>
                    </div>
                </li>
            </ul>
        </section>
    
    <section>
        <h6>RESOURCES</h6>
        <ul class="pmc-sidebar__resources">
        
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_similar_articles"
                            data-ga-label="/pmc/articles/PMC11126829/"
                            class="usa-accordion-button"
                            aria-controls="similar-articles-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_similar_articles"
                            data-action-close="close_similar_articles"
                    >
                        Similar articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/similar-article-links/38799248/"
                            

                         class="usa-accordion-content pmc-sidebar__resources--citations" id="similar-articles-accordion-aside" aria-hidden="true">
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_cited_by"
                            data-ga-label="/pmc/articles/PMC11126829/"
                            class="usa-accordion-button"
                            aria-controls="cited-by-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_cited_by"
                            data-action-close="close_cited_by"
                    >
                        Cited by other articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/cited-by-links/38799248/"
                            
                            class="usa-accordion-content pmc-sidebar__resources--citations"
                            id="cited-by-accordion-aside"
                            aria-hidden="true"
                    >
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/pmc/articles/PMC11126829/"
                            class="usa-accordion-button"
                            aria-controls="links-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                    >
                        Links to NCBI Databases
                    </button>
                    <div data-source-url="/pmc/resources/db-links/11126829/" class="usa-accordion-content" id="links-accordion-aside" aria-hidden="true"></div>
                </div>
            </li>

            
        
        </ul>
    </section>

 </div>

    </aside>
</main>

    <div class="overlay" role="dialog" aria-label="Citation Dialog">
  <div class="dialog citation-dialog">
    <button class="close-overlay" tabindex="1">[x]</button>
    <div class="title">Cite</div>
    <div class="citation-text-block">
  <div class="citation-text"></div>
  <div class="citation-actions">
    <button
      class="copy-button dialog-focus"
      data-ga-category="save_share"
      data-ga-action="cite"
      data-ga-label="copy"
      tabindex="2">
      Copy
    </button>

      <a href="#"
              class="export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
          <span class="title">Download .nbib</span>
          <span class="title-mobile">.nbib</span>
      </a>


    

<div class="citation-style-selector-wrapper">
  <label class="selector-label">Format:</label>
  <select aria-label="Format" class="citation-style-selector" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
  </div>
</div>
  </div>
</div>

     <!-- ========== BEGIN FOOTER ========== -->
 <footer>
      <section class="icon-section">
        <div id="icon-section-header" class="icon-section_header">Follow NCBI</div>
        <div class="grid-container container">
          <div class="icon-section_container">
            <a class="footer-icon" id="footer_twitter" href="https://twitter.com/ncbi" aria-label="Twitter"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <defs>
                  <style>
                    .cls-11 {
                      fill: #737373;
                    }
                  </style>
                </defs>
                <title>Twitter</title>
                <path class="cls-11"
                  d="M250.11,105.48c-7,3.14-13,3.25-19.27.14,8.12-4.86,8.49-8.27,11.43-17.46a78.8,78.8,0,0,1-25,9.55,39.35,39.35,0,0,0-67,35.85,111.6,111.6,0,0,1-81-41.08A39.37,39.37,0,0,0,81.47,145a39.08,39.08,0,0,1-17.8-4.92c0,.17,0,.33,0,.5a39.32,39.32,0,0,0,31.53,38.54,39.26,39.26,0,0,1-17.75.68,39.37,39.37,0,0,0,36.72,27.3A79.07,79.07,0,0,1,56,223.34,111.31,111.31,0,0,0,116.22,241c72.3,0,111.83-59.9,111.83-111.84,0-1.71,0-3.4-.1-5.09C235.62,118.54,244.84,113.37,250.11,105.48Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_facebook" href="https://www.facebook.com/ncbi.nlm" aria-label="Facebook"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <title>Facebook</title>
                <path class="cls-11"
                  d="M210.5,115.12H171.74V97.82c0-8.14,5.39-10,9.19-10h27.14V52l-39.32-.12c-35.66,0-42.42,26.68-42.42,43.77v19.48H99.09v36.32h27.24v109h45.41v-109h35Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_linkedin"
              href="https://www.linkedin.com/company/ncbinlm"
              aria-label="LinkedIn"><svg data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <title>LinkedIn</title>
                <path class="cls-11"
                  d="M101.64,243.37H57.79v-114h43.85Zm-22-131.54h-.26c-13.25,0-21.82-10.36-21.82-21.76,0-11.65,8.84-21.15,22.33-21.15S101.7,78.72,102,90.38C102,101.77,93.4,111.83,79.63,111.83Zm100.93,52.61A17.54,17.54,0,0,0,163,182v61.39H119.18s.51-105.23,0-114H163v13a54.33,54.33,0,0,1,34.54-12.66c26,0,44.39,18.8,44.39,55.29v58.35H198.1V182A17.54,17.54,0,0,0,180.56,164.44Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_github" href="https://github.com/ncbi" aria-label="GitHub"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <defs>
                  <style>
                    .cls-11,
                    .cls-12 {
                      fill: #737373;
                    }

                    .cls-11 {
                      fill-rule: evenodd;
                    }
                  </style>
                </defs>
                <title>GitHub</title>
                <path class="cls-11"
                  d="M151.36,47.28a105.76,105.76,0,0,0-33.43,206.1c5.28,1,7.22-2.3,7.22-5.09,0-2.52-.09-10.85-.14-19.69-29.42,6.4-35.63-12.48-35.63-12.48-4.81-12.22-11.74-15.47-11.74-15.47-9.59-6.56.73-6.43.73-6.43,10.61.75,16.21,10.9,16.21,10.9,9.43,16.17,24.73,11.49,30.77,8.79,1-6.83,3.69-11.5,6.71-14.14C108.57,197.1,83.88,188,83.88,147.51a40.92,40.92,0,0,1,10.9-28.39c-1.1-2.66-4.72-13.42,1-28,0,0,8.88-2.84,29.09,10.84a100.26,100.26,0,0,1,53,0C198,88.3,206.9,91.14,206.9,91.14c5.76,14.56,2.14,25.32,1,28a40.87,40.87,0,0,1,10.89,28.39c0,40.62-24.74,49.56-48.29,52.18,3.79,3.28,7.17,9.71,7.17,19.58,0,14.15-.12,25.54-.12,29,0,2.82,1.9,6.11,7.26,5.07A105.76,105.76,0,0,0,151.36,47.28Z">
                </path>
                <path class="cls-12"
                  d="M85.66,199.12c-.23.52-1.06.68-1.81.32s-1.2-1.06-.95-1.59,1.06-.69,1.82-.33,1.21,1.07.94,1.6Zm-1.3-1">
                </path>
                <path class="cls-12"
                  d="M90,203.89c-.51.47-1.49.25-2.16-.49a1.61,1.61,0,0,1-.31-2.19c.52-.47,1.47-.25,2.17.49s.82,1.72.3,2.19Zm-1-1.08">
                </path>
                <path class="cls-12"
                  d="M94.12,210c-.65.46-1.71,0-2.37-.91s-.64-2.07,0-2.52,1.7,0,2.36.89.65,2.08,0,2.54Zm0,0"></path>
                <path class="cls-12"
                  d="M99.83,215.87c-.58.64-1.82.47-2.72-.41s-1.18-2.06-.6-2.7,1.83-.46,2.74.41,1.2,2.07.58,2.7Zm0,0">
                </path>
                <path class="cls-12"
                  d="M107.71,219.29c-.26.82-1.45,1.2-2.64.85s-2-1.34-1.74-2.17,1.44-1.23,2.65-.85,2,1.32,1.73,2.17Zm0,0">
                </path>
                <path class="cls-12"
                  d="M116.36,219.92c0,.87-1,1.59-2.24,1.61s-2.29-.68-2.3-1.54,1-1.59,2.26-1.61,2.28.67,2.28,1.54Zm0,0">
                </path>
                <path class="cls-12"
                  d="M124.42,218.55c.15.85-.73,1.72-2,1.95s-2.37-.3-2.52-1.14.73-1.75,2-2,2.37.29,2.53,1.16Zm0,0"></path>
              </svg></a>
            <a class="footer-icon" id="footer_blog" href="https://ncbiinsights.ncbi.nlm.nih.gov/" aria-label="Blog">
              <svg id="Layer_1" data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 40 40"><defs><style>.cls-1{fill:#737373;}</style></defs><path class="cls-1" d="M14,30a4,4,0,1,1-4-4,4,4,0,0,1,4,4Zm11,3A19,19,0,0,0,7.05,15a1,1,0,0,0-1,1v3a1,1,0,0,0,.93,1A14,14,0,0,1,20,33.07,1,1,0,0,0,21,34h3a1,1,0,0,0,1-1Zm9,0A28,28,0,0,0,7,6,1,1,0,0,0,6,7v3a1,1,0,0,0,1,1A23,23,0,0,1,29,33a1,1,0,0,0,1,1h3A1,1,0,0,0,34,33Z"/></svg>
            </a>
          </div>
        </div>
      </section>

      <section class="container-fluid bg-primary">
        <div class="container pt-5">
          <div class="row mt-3">
            <div class="col-lg-3 col-12">
              <p><a class="text-white" href="https://www.nlm.nih.gov/socialmedia/index.html">Connect with NLM</a></p>
              <ul class="list-inline social_media">
                <li class="list-inline-item"><a href="https://twitter.com/NLM_NIH" aria-label="Twitter"
                    target="_blank" rel="noopener noreferrer"><svg version="1.1" xmlns="http://www.w3.org/2000/svg"
                      xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 249 249"
                      style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <style type="text/css">
                        .st20 {
                          fill: #FFFFFF;
                        }

                        .st30 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }
                      </style>
                      <title>SM-Twitter</title>
                      <g>
                        <g>
                          <g>
                            <path class="st20" d="M192.9,88.1c-5,2.2-9.2,2.3-13.6,0.1c5.7-3.4,6-5.8,8.1-12.3c-5.4,3.2-11.4,5.5-17.6,6.7
                                                c-10.5-11.2-28.1-11.7-39.2-1.2c-7.2,6.8-10.2,16.9-8,26.5c-22.3-1.1-43.1-11.7-57.2-29C58,91.6,61.8,107.9,74,116
                                                c-4.4-0.1-8.7-1.3-12.6-3.4c0,0.1,0,0.2,0,0.4c0,13.2,9.3,24.6,22.3,27.2c-4.1,1.1-8.4,1.3-12.5,0.5c3.6,11.3,14,19,25.9,19.3
                                                c-11.6,9.1-26.4,13.2-41.1,11.5c12.7,8.1,27.4,12.5,42.5,12.5c51,0,78.9-42.2,78.9-78.9c0-1.2,0-2.4-0.1-3.6
                                                C182.7,97.4,189.2,93.7,192.9,88.1z"></path>
                          </g>
                        </g>
                        <circle class="st30" cx="124.4" cy="128.8" r="108.2"></circle>
                      </g>
                    </svg></a></li>
                <li class="list-inline-item"><a href="https://www.facebook.com/nationallibraryofmedicine"
                    aria-label="Facebook" rel="noopener noreferrer" target="_blank">
                    <svg version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px"
                      y="0px" viewBox="0 0 249 249" style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <style type="text/css">
                        .st10 {
                          fill: #FFFFFF;
                        }

                        .st110 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }
                      </style>
                      <title>SM-Facebook</title>
                      <g>
                        <g>
                          <path class="st10" d="M159,99.1h-24V88.4c0-5,3.3-6.2,5.7-6.2h16.8V60l-24.4-0.1c-22.1,0-26.2,16.5-26.2,27.1v12.1H90v22.5h16.9
                                                      v67.5H135v-67.5h21.7L159,99.1z"></path>
                        </g>
                      </g>
                      <circle class="st110" cx="123.6" cy="123.2" r="108.2"></circle>
                    </svg>
                  </a></li>
                <li class="list-inline-item"><a href="https://www.youtube.com/user/NLMNIH" aria-label="Youtube"
                    target="_blank" rel="noopener noreferrer"><svg version="1.1" xmlns="http://www.w3.org/2000/svg"
                      xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 249 249"
                      style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <title>SM-Youtube</title>
                      <style type="text/css">
                        .st4 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }

                        .st5 {
                          fill: #FFFFFF;
                        }
                      </style>
                      <circle class="st4" cx="124.2" cy="123.4" r="108.2"></circle>
                      <g transform="translate(0,-952.36218)">
                        <path class="st5"
                          d="M88.4,1037.4c-10.4,0-18.7,8.3-18.7,18.7v40.1c0,10.4,8.3,18.7,18.7,18.7h72.1c10.4,0,18.7-8.3,18.7-18.7
                                            v-40.1c0-10.4-8.3-18.7-18.7-18.7H88.4z M115.2,1058.8l29.4,17.4l-29.4,17.4V1058.8z"></path>
                      </g>
                    </svg></a></li>
              </ul>
            </div>
            <div class="col-lg-3 col-12">
              <p class="address_footer text-white">National Library of Medicine<br>
                <a href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/@38.9959508,-77.101021,17z/data=!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb:0x19156f88b27635b8!8m2!3d38.9959508!4d-77.0988323"
                  class="text-white" target="_blank" rel="noopener noreferrer">8600 Rockville Pike<br>
                  Bethesda, MD 20894</a></p>
            </div>
            <div class="col-lg-3 col-12 centered-lg">
              <p><a href="https://www.nlm.nih.gov/web_policies.html" class="text-white">Web Policies</a><br>
                <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office"
                  class="text-white">FOIA</a><br>
                <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="text-white" id="vdp">HHS Vulnerability Disclosure</a></p>
            </div>
            <div class="col-lg-3 col-12 centered-lg">
              <p><a class="supportLink text-white" href="https://support.nlm.nih.gov/">Help</a><br>
                <a href="https://www.nlm.nih.gov/accessibility.html" class="text-white">Accessibility</a><br>
                <a href="https://www.nlm.nih.gov/careers/careers.html" class="text-white">Careers</a></p>
            </div>
          </div>
          <div class="row">
            <div class="col-lg-12 centered-lg">
              <nav class="bottom-links">
                <ul class="mt-3">
                  <li>
                    <a class="text-white" href="//www.nlm.nih.gov/">NLM</a>
                  </li>
                  <li>
                    <a class="text-white"
                  href="https://www.nih.gov/">NIH</a>
                  </li>
                  <li>
                    <a class="text-white" href="https://www.hhs.gov/">HHS</a>
                  </li>
                  <li>
                    <a
                  class="text-white" href="https://www.usa.gov/">USA.gov</a>
                  </li>
                </ul>
              </nav>
            </div>
          </div>
        </div>
      </section>
    </footer>
 <!-- ========== END FOOTER ========== -->
  <!-- javascript to inject NWDS meta tags. Note: value of nwds_version is updated by "npm version" command -->
 
  <script type="text/javascript">
    var nwds_version = "1.1.9-2";

    var meta_nwds_ver = document.createElement('meta');
    meta_nwds_ver.name = 'ncbi_nwds_ver';
    meta_nwds_ver.content = nwds_version;
    document.getElementsByTagName('head')[0].appendChild(meta_nwds_ver);

    var meta_nwds = document.createElement('meta');
    meta_nwds.name = 'ncbi_nwds';
    meta_nwds.content = 'yes';
    document.getElementsByTagName('head')[0].appendChild(meta_nwds);

	var alertsUrl = "/core/alerts/alerts.js";
	if (typeof ncbiBaseUrl !== 'undefined') {
		alertsUrl = ncbiBaseUrl + alertsUrl;
	}
  </script>



  
    <!-- JavaScript -->
    <script src="/pmc/static/CACHE/js/output.0f72d6a64937.js"></script>
  
  
    <script src="https://code.jquery.com/jquery-3.5.0.min.js"
          integrity="sha256-xNzN2a4ltkB44Mc/Jz3pT4iU1cmeR0FkXs4pru/JxaQ="
          crossorigin="anonymous">
    </script>
    <script>
        var fallbackJquery = "/pmc/static/base/js/jquery-3.5.0.min.js";
        window.jQuery || document.write("<script src=" + fallbackJquery + ">\x3C/script>")
    </script>
  

  <script src="/pmc/static/CACHE/js/output.a212a9fcf845.js"></script>
<script src="/pmc/static/CACHE/js/output.7999321d1aac.js"></script>
<script src="/pmc/static/CACHE/js/output.7ca436b2ea51.js"></script>
<script src="/pmc/static/CACHE/js/output.f8422046fbe0.js"></script>
<script src="/pmc/static/CACHE/js/output.ff40c7d85ff8.js"></script>
<script src="/pmc/static/CACHE/js/output.a6a84a0ad361.js"></script>

<script type="text/javascript" src="/pmc/static/bundles/base/base.038d36e4e31104b40a19.js" ></script>

    <script type="text/javascript">
        if(typeof jQuery !=='undefined') {
            jQuery.migrateMute = true;
        }
    </script>
    <script type="text/javascript" src="https://code.jquery.com/jquery-migrate-1.4.1.js"></script>
    <script type="text/javascript" src="/core/jig/1.15.2/js/jig.nojquery.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/crb.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/jactions.min.js?_=3.18">//</script><script type="text/javascript">window.name="mainwindow";</script>

    <script type="text/javascript">var exports = {};</script>
    <script src="/pmc/static/CACHE/js/output.340a3b9cce7f.js"></script>
<script src="/pmc/static/CACHE/js/output.228f96f3298e.js"></script>
    <script type="text/javascript" src="/pmc/static/bundles/article/article.b7dd20e527283dd68f45.js" ></script>
    <script type="text/javascript">
        window.ncbi.pmc.articlePage.init({ pageURL: '/pmc/articles/PMC11126829/', citeCookieName: 'pmc-cf'});
    </script>


  
  
  <script  type="text/javascript" src="https://www.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


  
      
  

</body>
</html>
